The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle

  • Michel Jouvet
Conference paper
Part of the Ergebnisse der Physiologie, biologischen Chemie und experimentellen Pharmakologie book series (ERGEBPHYSIOL, volume 64)


Locus Coeruleus Reticular Formation Paradoxical Sleep Medial Forebrain Bundle Mesencephalic Reticular Formation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Acheson, G. H. (ed.): Proceed. of second Symposium on catecholamines. Pharmacol. Rev. 18, 803 (1966). Baltimore: The Williams & Wilkins.Google Scholar
  2. Aghajanian, G. K., Bloom, F. E.: Electron-microscopic localization of tritiated norepinephrine in rat brain: effect of drugs. J. Pharmacol. exp. Ther. 156, 407–417 (1967a).PubMedGoogle Scholar
  3. — —Localization of tritiated serotonin in rat brain by electron microscopic autoradiography. J. Pharmacol. exp. Ther. 156, 23–31 (1967b).PubMedGoogle Scholar
  4. — — Lovell, R. A., Sheard, M. H., Freedman, D. X.: The uptake of 5-hydroxy-tryptamine-3H from the cerebral ventricles: autoradiographic localization. Biochem. Pharmacol. 15, 401–408 (1966).Google Scholar
  5. — Foote, W. E., Sheard, M. H.: Action of psychotogenic drugs on single midbrain raphe neurons. J. Pharmacol. exp. Ther. 171, 178–187 (1970a).PubMedGoogle Scholar
  6. — Graham, A. W., Sheard, M. H.: Serotonin containing neurons in brain: depression of firing by monoamine oxidase inhibitors. Science 169, 1100–1102 (1970b).PubMedGoogle Scholar
  7. — Rosecrans, J. A., Sheard, M. H.: Serotonin: release in the forebrain by stimulation of midbrain raphe. Science 156, 402–403 (1967c).PubMedGoogle Scholar
  8. — Roth, R. H.: Gamma-hydroxybutyrate induced increase in brain dopamine: localization by fluorescence microscopy. J. Pharmacol. exp. Ther. 175, 131–138 (1970).PubMedGoogle Scholar
  9. — Weiss, T.: LSD blocks the increase in rat brain serotonin turnover induced by an elevated ambient temperature. Nature (Lond.) 220, 795–796 (1968).PubMedGoogle Scholar
  10. Ajuriaguerra, J. de (ed.): Monoamines et système nerveux central. 293 pp. Genève: Georg 1962.Google Scholar
  11. Akert, K., Koella, W. P., Hess, R.: Sleep produced by electrical stimulation of the thalamus. Amer. J. Physiol. 168, 260–267 (1952).PubMedGoogle Scholar
  12. — Moor, H., Pfenninger, K., Sandri, C.: Contributions of new impregnation methods and freeze etching to the problems of synaptic fine structure. Progr. Brain Res. 31, 223–240 (1969).Google Scholar
  13. Waser, P. G. (eds.): Mechanisms of synaptic transmission. Progr. Brain Res. 31 (1969).Google Scholar
  14. Akindele, M. O., Evans, J. I., Oswald, I.: Monoamine oxidase inhibitors, sleep and mood. Electroenceph. clin. Neurophysiol. 29, 47–56 (1970).PubMedGoogle Scholar
  15. Alberici, M., Rodriguez de Lores Arnaiz, G., Robertis, E. de: Catechol-o-methyltransferase in nerve endings of rat brain. Life Sci. 4, 1951–1961 (1965).PubMedGoogle Scholar
  16. Albert, I., Cicala, G., Siegel, J.: The behavioral effects of REM sleep deprivation in rats. Psychophysiology 6, 550–560 (1970).PubMedGoogle Scholar
  17. Alekseyeva, T. T.: Correlation of nervous and humoral factors in the development of sleep in non-dijointed twins. [Russian.] Zh. vyssh. nerv. Deyat. Pavlova 8, 835–844 (1958).Google Scholar
  18. Alivisatos, S. G., Papaphilis, A. D., Ungar, F., Seth, P. K.: Chemical nature of binding on serotonin in the central nervous system. Nature (Lond.) 226, 455–456 (1970).PubMedGoogle Scholar
  19. — Ungar, F., Parmar, S. S., Seth, P. K.: Monoamine oxidase dependent upon labeling in vitro of mouse brain by 14 C-Serotonin. Biochem. Pharmacol. 17, 1993–1997 (1968).PubMedGoogle Scholar
  20. Amin, A. H., Crawford, I. B., Gaddum, J. H.: The distribution of substance P and serotonin in the central nervous system of the dog. J. Physiol. (Lond.) 126, 596–618 (1954).PubMedGoogle Scholar
  21. Andén, N. E., Butcher, S. G., Engel, J.: Central dopamine and noradrenaline receptor activity of the amines formed from m-tyrosine, alpha-methyl-m-tyrosine and alpha-methyldopa. J. Pharm. Pharmacol. 22, 548–550 (1970).PubMedGoogle Scholar
  22. — Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N. A., Larsson, K.: Demonstration and mapping out of nigro-neostriatal dopamine neurons. Life Sci. 3, 523–531 (1964a).PubMedGoogle Scholar
  23. Andén, N. E., Carlsson, A., Hillarp, N. A., Magnusson, T.: Noradrenaline release by nerve stimulation of the spinal cord. Life Sci. 4, 129–133 (1965a).PubMedGoogle Scholar
  24. — Corrodi, H., Dahlström, A., Fuxe, K., Hökfelt, T.: Effects of tyrosine hydroxylase inhibition on the amine levels of central monoamine neurons. Life Sci. 5, 561–569 (1966a).Google Scholar
  25. — — Fuxe, K., Hökfelt, T.: Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide. Brit. J. Pharmacol. 34, 1–8 (1968).Google Scholar
  26. — Dahlström, A., Fuxe, K., Larsson, K.: Functional role of the nigro-neostriatal dopamine neurons. Acta pharmacol. (Kbh.) 24, 255–263 (1966b).Google Scholar
  27. — — — —Mapping out of catecholamine and 5-hydroxytryptamine neurons innervating the telencephalon and diencephalon. Life Sci. 4, 1275–1281 (1965b).PubMedGoogle Scholar
  28. — — — — Olson, L., Ungerstedt, U.: Ascending monoamine neurons to the telencephalon and diencephalon. Acta physiol. scand. 67, 313–327 (1966d).Google Scholar
  29. — — — Olson, L., Ungerstedt, A.: Ascending noradrenalin neurons from the pons and the medulla oblongata. Experientia (Basel) 22, 44–45 (1966c).PubMedGoogle Scholar
  30. — Fuxe, K. Hamberger, G. Hökfelt, T.: A quantitative study on the nigro-neostriatal dopamine neuron system in the rat. Acta physiol. scand. 67, 306–313 (1966e).PubMedGoogle Scholar
  31. — — Henning, M.: Mechanisms of noradrenaline and 5-hydroxytryptamine disappearance induced by alpha-methyl-dopa and alpha-methyl-metatyrosine. Europ. J. Pharmacol. 8, 302–309 (1969).Google Scholar
  32. — — Hökfelt, T.: The importance of the nervous impulse flow for the depletion of the monoamines from central neurones by some drugs. J. Pharm. Pharmacol. 18, 630–632 (1966f).PubMedGoogle Scholar
  33. — — Larsson, K.: Effect of large mesencephalic-diencephalic lesions on the noradrenalin, dopamine and 5-hydroxytryptamine neurons of the central nervous system. Experientia (Basel) 22, 842–844 (1966g).PubMedGoogle Scholar
  34. — Haggendal, T., Magnusson, T., Rosengren, E.: The time course of the disappearance of noradrenaline and 5-hydroxytryptamine in the spinal cord after transection. Acta physiol. scand. 62, 115–119 (1964b).PubMedGoogle Scholar
  35. Andersen, P., Curtis, D. R.: The excitation of thalamic neurones by acetylcholine. Acta physiol. scand. 61, 85–100 (1964).PubMedGoogle Scholar
  36. Angeleri, F., Marchesi, G. F., Quattrini, A.: Effects of chronic thalamic lesions on the electrical activity of the neocortex and on sleep. Arch. ital. Biol. 107, 633–668 (1969).Google Scholar
  37. Antonelli, A. R., Bertaccini, G., Montegazzini, P.: Relationship between mesencephalic-hypothalamic concentration of 5-hydroxytryptamine and cortical activity of cats. J. Neurochem. 8, 157–158 (1961).PubMedGoogle Scholar
  38. Aprison, M. H.: On a proposed theory for the mechanism of action of sertonin in brain. In: Recent adv. biol. psychiat., p. 133–146. New York: Plenum Press 1962.Google Scholar
  39. — Hingtgen, J. H.: Brain acetylcholine and excitation in avoidance behaviour. Biol. Psychiat. 1, 87–89 (1969).PubMedGoogle Scholar
  40. — Kariya, T., Hingtgen, J. N., Toru, M.: Neurochemical correlates of behaviour, changes in acetylcholine, norepinephrine and 5-hydroxytryptamine concentrations in several discrete brain areas of the rat during behavioural excitation. J. Neurochem. 15, 1131–1141 (1968a).PubMedGoogle Scholar
  41. — — — —Neurochemical correlates of behaviour. J. Neurochem. 15, 1131–1139 (1968b).PubMedGoogle Scholar
  42. Arbuthnott, G. W., Crow, T. J., Fuxe, K., Olson, L., Ungerstedt, U.: Depletion of catecholamines in vitro induced by electrical stimulation of central monoamine pathways. Brain Res. 24, 471–483 (1970).PubMedGoogle Scholar
  43. — Fuxe, K., Ungerstedt, U.: Central catecholamine turnover and self stimulation behaviour. Brain Res. 27, 406–413 (1971).PubMedGoogle Scholar
  44. Arduini, A., Pinneo, L. R.: A method for the quantification of tonic activity in the nervous system. Arch. ital. Biol. 100, 415–424 (1962).PubMedGoogle Scholar
  45. Astic, L., Jouvet-Mounier, D.: Mise en évidence du sommeil paradoxal in utero chez le cobaye. C. R. Acad. Sci. (Paris) 264, 2578–2581 (1969).Google Scholar
  46. Axelrod, J.: The uptake and release of catecholamines and the effect of drugs. In: Biogenic amines. A symposium (H. Himwich and W. A. Himwich, eds.). Amsterdam: Elsevier 1962.Google Scholar
  47. Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines. Pharmacol. Rev. 18, 95–113 (1966).PubMedGoogle Scholar
  48. Axelsson, J.: Catecholamine functions. Ann. Rev. Physiol. 33, 1–31 (1971).Google Scholar
  49. Bak, I. J.: The ultrastructure of the substantia nigra and caudate nucleus of the mouse and the cellular localization of catecholamines. Exp. Brain Res. 3, 40–58 (1967).Google Scholar
  50. Baldissera, F., Cesa-Bianchi, M. G., Mancia, M.: Responses of visual cortex to transcallosal and geniculate stimulations during sleep and wakefulness. Arch. ital. Biol. 104, 247–263 (1966).PubMedGoogle Scholar
  51. Balzano, E., Jeannerod, M.: Activité multi-unitaire de structures sous-corticales pendant le cycle veille-sommeil chez le chat. Electroenceph. clin. Neurophysiol. 28, 136–145 (1970).PubMedGoogle Scholar
  52. Bandler, R.: Agression induced in rats by cholinergic stimulation of hypothalamus. Nature (Lond.) 224, 1035–1036 (1969).PubMedGoogle Scholar
  53. Barchas, J.: Relation of melatonin to sleep. Proc. West. Pharmacol. Soc. 11, 22–23 (1968).PubMedGoogle Scholar
  54. Barchas, J. D., Ciaranello, R. D., Steinman, A. M.: Epinephrine formation and metabolism in mammalian brain. Biol. Psychiat. 1, 31–48 (1969).PubMedGoogle Scholar
  55. Bard, P., Macht, M. B.: The behaviour of chronically decerebrate cats. In: Neurological basis of behaviour. A Ciba Foundation Symposium, p. 55–71. London: Churchill 1958.Google Scholar
  56. Bartholini, G., Birlard, W. P., Pletscher, A., Bates, H. M.: Increase of cerebral catecholamines caused by 3,4 dihydroxyphenylalanine after inhibition of peripheral decarboxylase. Nature 215, 852–853 (1967).PubMedGoogle Scholar
  57. — Prada, M. da, Pletscher, A.: Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extra cerebral decarboxylase. J. Pharm. Pharmacol. 20, 228–229 (1968a).PubMedGoogle Scholar
  58. — Pletscher, A.: Cerebral accumulation and metabolism of C14 dopa after selective inhibition of peripheral decarboxylase. J. Pharmacol. exp. Ther. 161, 14–20 (1968b).PubMedGoogle Scholar
  59. — —Effect of various decarboxylase inhibitors in the cerebral metabolism of dihydroxyphenylalanine. J. Pharm. Pharmacol. 21, 323–324 (1969).PubMedGoogle Scholar
  60. — — Richards, J.: 6-Hydroxydopamine induced inhibition of brain catecholamine synthesis without ultra structural damage. Experientia (Basel) 26, 598–600 (1970b).PubMedGoogle Scholar
  61. — Richards, J. G., Pletscher, A.: Dissociation between biochemical and ultrastructural effects of 6-hydroxydopamine in rat brain. Experientia (Basel) 26, 142–144 (1970a).PubMedGoogle Scholar
  62. Bartlet, A. L.: The influence of chlorpromazine on the metabolism of 5-hydroxytryptamine in the mouse. Brit. J. Pharmacol. Chemother. 24, 497–510 (1965).Google Scholar
  63. Bartolini, A., Pepeu, G.: Investigations into the acetylcholine output from the cerebral cortex of the cat in the presence of hyoscine. Brit. J. Pharmacol. Chemother. 31, 66–74 (1967).Google Scholar
  64. Batini, C., Moruzzi, G., Palestini, M., Rossi, G. F., Zanchetti, A.: Effects of complete pontine transections on the sleep-wakefulness rhythm: the midpontine pretrigeminal preparation. Arch. ital. Biol. 97, 1–12 (1959).Google Scholar
  65. Batsel, H. L.: Electroencephalographic synchronization and desynchronization in the chronic “cerveau isolé” of the dog. Electroenceph. clin. Neurophysiol. 12, 421–430 (1960).PubMedGoogle Scholar
  66. Baust, W., Niemczyk, H.: Studies on the adrenaline-sensitive component the mesencephalic reticular formation. J. Neurophysiol. 26, 692–705 (1963).PubMedGoogle Scholar
  67. — —Further studies on the action of adrenergic drugs on cortical activity. Electroenceph. clin. Neurophysiol. 17, 261–271 (1964).PubMedGoogle Scholar
  68. Baust, W., Niemczyk, H., Vieth, J.: The action of blood pressure on the ascending reticular activating system with special reference to adrenaline induced EEG arousal. Electroenceph. clin. Neurophysiol. 15, 63–72 (1963).PubMedGoogle Scholar
  69. Baxter, B. L.: Elicitation of emotional behavior by electrical or chemical stimulation applied at the same loci in cat mesencephalon. Exp. Neurol. 21, 1–11 (1968).PubMedGoogle Scholar
  70. Induction of both emotional behavior and a novel form of REM sleep by chemical stimulation applied to cat mesencephalon. Exp. Neurol. 23, 220–230 (1969).PubMedGoogle Scholar
  71. Beani, L., Bianchi, C., Santinoceto, L., Marchetti, P.: The cerebral acetylcholine release in conscious rabbits with semi-permanently implanted epidural cups. Int. J. Neuropharmacol. 7, 469–481 (1968).PubMedGoogle Scholar
  72. Bedard, P., Larochelle, L., Parent, A., Poirier, L. J.: The nigrostriatal pathway: a correlative study based on neuroanatomical and neurochemical criteria in the cat and the monkey. Exp. Neurol. 25, 365–377 (1969a).PubMedGoogle Scholar
  73. — — — —Dopamine and serotonin in the striatum of the cat. Arch. Neurol. (Chic.) 20, 239–242 (1969b).PubMedGoogle Scholar
  74. Beleslin, D. B., Myers, R. D.: The release of acetylcholine and 5-hydroxytryptamine from the mesencephalon of the unanesthetized rhesus monkey. Brain Res. 23, 437–442 (1970).PubMedGoogle Scholar
  75. Bell, L., Iversen, L. L., Uretsky, N. J.: Time course of the effects of 6-hydroxydopamine on catecholamine containing neurones in rat hypothalamus and striatum. Brit. J. Pharmacol. 4, 790–799 (1970).Google Scholar
  76. Belugou, J. L., Benoit, O., Leygonie, F.: Décharges neuronales de l’hippocampe au cours de la veille et du sommeil. J. Physiol. (Paris) 60 (Suppl. 2), 399 (1968).Google Scholar
  77. Benda, P., Perles, R.: Etude expérimentale de l’abaissement de la vigilance par le gamma butyrolactone. C. R. Acad. Sci. (Paris) 251, 1312–1313 (1960).Google Scholar
  78. Benoit, O.: Activité unitaire du nerf optique, du corps genouillé latéral et de la formation réticulaire durant les différents stades du sommeil. J. Physiol. (Paris) 56, 259–262 (1964).Google Scholar
  79. Influences toniques et phasiques exercées par le sommeil sur l’activité de la voie visuelle. J. Physiol. (Paris) 59, 295–317 (1967).Google Scholar
  80. — Influence des états de sommeil sur l’activité spontanée et la transmission dans les voies et les relais sensitifs et visuels. Thèse de Sciences, Paris, 1971. 235 pp.Google Scholar
  81. Berger, B. D., Stein, L.: An analysis of the learning deficits produced by scopolamine. Psychopharmacologia (Berl.) 14, 271–284 (1969).PubMedGoogle Scholar
  82. Berlucchi, G.: Callosal activity in unrestrained, unanesthetized cats. Arch. ital. Biol. 103, 623–635 (1965).PubMedGoogle Scholar
  83. — Maffei, L., Moruzzi, G., Strata, P.: Mécanismes hypnogènes du tronc de l’encéphale antagonistes du système réticulaire activateur. In: Aspects anatomo-fonctionnels de la physiologie du sommeil (Jouvet, M., ed.), p. 89–105. Paris: Centre National de la Recherche Scientifique 1965.Google Scholar
  84. Bessman, S. P., Fishbein, W. N.: Gamma hydroxybutyrate, a normal brain metabolite. Nature (Lond.) 200, 1207 (1963).PubMedGoogle Scholar
  85. Bizzi, E.: Changes in the orthodromic and antidromic response of optic tract during the eye movements of sleep. J. Neurophysiol. 29, 861–871 (1966a).PubMedGoogle Scholar
  86. Discharge patterns of single geniculate neurons during the rapid eye movements of sleep. J. Neurophysiol. 29, 1087–1096 (1966b).PubMedGoogle Scholar
  87. — Brooks, D. C.: Functional connections between pontine reticular formation and lateral geniculate nucleus during deep sleep. Arch. ital. Biol. 101, 666–680 (1963).PubMedGoogle Scholar
  88. Blaschko, H., Burn, J. H., Langemann, H.: The formation of noradrenaline from dihydroxyphenylserine. Brit. J. Pharmacol. Chemother. 5, 431–437 (1950).Google Scholar
  89. Bliss, E. L., Ailion, J., Zwanziger J.: Metabolism of norepinephrine, serotonin and dopamine in rat brain with stress. J. Pharmacol. exp. Ther. 164, 122–134 (1968).PubMedGoogle Scholar
  90. — Zwanziger, J.: Brain amines and emotional stress. J. Psychiat. Res. 4, 189–199 (1966).PubMedGoogle Scholar
  91. Bloom, F. E.: Lesions of central norepinephrine terminals with 6-hydroxy-dopamine: chemistry and fine structure. Science 166, 1284–1286 (1969).PubMedGoogle Scholar
  92. — Aghajanian, G. K.: An electron microscopic analysis of large granular synaptic vesicles of the brain in relation to monoamine content. J. Pharmacol. exp. Ther. 159, 261–273 (1968).PubMedGoogle Scholar
  93. — Costa, E., Salmoiraghi, G. C.: Analysis of individual rabbit olfactory bulb neuron responses to the microelectrophoresis of acetylcholine, norepinephrine and serotonin synergists and antagonists. J. Pharmacol. exp. Ther. 146, 16–24 (1964).PubMedGoogle Scholar
  94. — Giarman, N. J.: Physiologic and pharmacologic considerations of biogenic amines in the nervous system. Ann. Rev. Pharmacol. 8, 229–259 (1968).PubMedGoogle Scholar
  95. Boakes, R. J., Bradley, P. B., Briggs, I., Dray, A.: Effects of lysergic acid derivatives on 5-hydroxytryptamine excitations of brain stem neurons. Brit. J. Pharmacol. 38, 453–454 (1970a).Google Scholar
  96. — — — —Antagonism of 5-hydroxytryptamine by LSD 25 in the central nervous system: a possible neuronal basis for the actions of LSD 25. Brit. J. Pharmacol. 40, 202–218 (1970b).Google Scholar
  97. — — Brookes, N., Candy, J. M., Stencroft, J. H.: Effects of noradrenaline and its analogues on brain stem neurons. J. Physiol. (Lond.) 201, 20 (1969).Google Scholar
  98. Bobillier, P., Mouret, J. R.: Sleep and brain biogenic amines diurnal rhythms in the rat. II. Alterations of brain biogenic amines diurnal rhythms independent of light. Int. J. Neurosciences 2, 271–281 (1971).Google Scholar
  99. Bokums, J. A., Elliott, H. W.: Effects of physostigmine in electrical activity of the cat brain. Pharmacology 1, 98–111 (1968).PubMedGoogle Scholar
  100. Bonvallet, M., Allen, B. J.: Prolonged spontaneous and evoked reticular activation following discrete bulbar lesions. Electroenceph. clin. Neurophysiol. 15, 969–988 (1963).PubMedGoogle Scholar
  101. — Bloch, V.: Bulbar control of cortical arousal. Science 133, 1133–1134 (1961).PubMedGoogle Scholar
  102. — Dell, P.: Contrôle bulbaire du système activateur. In: Aspects anatomo-fonctionnels de la physiologie du sommeil (Jouvet, M., ed.). Paris: Centre National de la Recherche Scientifique 1965.Google Scholar
  103. — —: Sinus carotidien et activité électrique cérébrale. C. R. Soc. Biol. (Paris) 147, 1166–1170 (1953).Google Scholar
  104. — — —Tonus sympathique et activité électrique corticale. Electroenceph. clin. Neurophysiol. 6, 119–144 (1954).PubMedGoogle Scholar
  105. Bourne, G. H. (ed.): The structure and function of nervous tissue. Vol. III Biochemistry and disease. New York: Academic Press 1969.Google Scholar
  106. Bowers, M. B., Hartmann, E. L., Freedman, D. X.: Sleep deprivation and brain acetylcholine. Science 153, 1416–1417 (1966).PubMedGoogle Scholar
  107. Bradley, P. B., Candy, J. M.: Iontophoretic release of acetylcholine, noradrenaline, 5-hydroxytryptamine and D-lysergic acid diethylamide from micropipettes. Brit. J. Pharmacol. 40, 194–202 (1970).Google Scholar
  108. — Dhawan, B. N. Wolstencroft, J. H. Pharmacological properties of cholinoceptive neurons in the medulla and pons of the cat. J. Physiol. (Lond.) 183, 658–675 (1966).PubMedGoogle Scholar
  109. — Elkes, J.: The effects of some drugs on the electrical activity of the brain. Brain 80, 77–117 (1957).PubMedGoogle Scholar
  110. — Key, B. J.: The effect of drugs on arousal responses produced by electrical stimulation of the reticular formation of the brain. Electroenceph. clin. Neurophysiol. 10, 97–110 (1958).PubMedGoogle Scholar
  111. — Wolstencroft, J. H.: Actions of drugs on single neurons in the brain stem. Brit. med. Bull. 21, 15–18 (1965).PubMedGoogle Scholar
  112. — — Hösli, L., Avanzino, G. L.: Neuronal basis for the central action of chlorpromazine. Nature (Lond.) 212, 1425–1428 (1966).PubMedGoogle Scholar
  113. Branchey, M., Kissin, B.: The effect of alpha methylparatyrosine on sleep and arousal in the rat. Psychosom. Sci. 19, 281–282 (1970).Google Scholar
  114. Brauchi, J. T., West, L. J.: Sleep deprivation. J. Amer. med. Ass. 171, 11–14 (1959).Google Scholar
  115. Breese, G. R., Dennis Traylor, T.: Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: evidence for selective degeneration of catecholamine neurons. J. Pharmacol. exp. Ther. 174, 413–420 (1970).PubMedGoogle Scholar
  116. Bremer, F.: The neurophysiological problem of sleep. In: Brain mechanisms and consciousness (Adrian, E. D., F. Bremer, and H. H. Jasper, eds.), p. 137–162. Oxford: Blackwell 1954.Google Scholar
  117. — Chatonnet, J.: Acétylcholine et cortex cérébral. Arch. intern. Physiol. 57, 106–109 (1949).Google Scholar
  118. Brodal, A., Taber, E., Walberg, F.: The raphe nuclei of the brain stem in the cat. II. Efferent connections. J. comp. Neurol. 114, 239–259 (1960a).Google Scholar
  119. — Walberg, F., Taber, E.: The raphe nuclei of the brain stem in the cat. III. Afferent connections. J. comp. Neurol. 114, 261–281 (1960b).Google Scholar
  120. Brodie, B. B., Comer, M. S., Costa, E., Dlabac, A.: The role of brain serotonin in the mechanism of the central action of reserpine. J. Pharmacol. exp. Ther. 152, 340–350 (1966).PubMedGoogle Scholar
  121. — Finger, K. F., Orlans, F. B., Quinn, G. P., Sulser, F.: Evidence that tranquillizing drug action of reserpine is associated with change in brain serotonin and not in brain norepinephrine. J. Pharmacol. exp. Ther. 129, 250–256 (1960).PubMedGoogle Scholar
  122. — Olin, J. S., Kuntzman, R. G., Shore, P. A.: Possible interrelationship between release of brain norepinephrine and serotonin by reserpine. Science 125, 1293–1294 (1957).PubMedGoogle Scholar
  123. — Shore, P. A.: On a role for serotonin and norepinephrine as chemical mediators in the central autonomic nervous system. In: Hormones, brain function and behaviour (Hoagland, H., ed.), p. 161–176. New York: Academic Press 1957.Google Scholar
  124. Brody, J. F.: Behavioral effects of serotonin depletion and p-chlorophenylalanine (a serotonin depletor in rats). Psychopharmacologia (Berl.) 17, 14–34 (1970).PubMedGoogle Scholar
  125. Brooks, D. C.: Localization and characteristics of the cortical waves associated with eye movement in the cat. Exp. Neurol. 22, 603–613 (1969).Google Scholar
  126. Localization of the lateral geniculate nucleus monophasic waves associated with paradoxical sleep in the cat. Electroenceph. clin. Neurophysiol. 23, 123–133 (1967a).PubMedGoogle Scholar
  127. Effect of bilateral optic nerve section on visual system monophasic wave activity in the cat. Electroenceph. clin. Neurophysiol. 23, 134–141 (1967).PubMedGoogle Scholar
  128. — Bizzi, E.: Brain stem electrical activity during deep sleep. Arch. ital. Biol. 101, 648–665 (1963).PubMedGoogle Scholar
  129. — Gershon, M. D.: Eye movement potentials in the oculomotor and visual system: A comparison in reserpine induced waves with those present during wakefulness and rapid eye movement sleep. Brain Res. 27, 223–239 (1971).PubMedGoogle Scholar
  130. Buguet, A.: Monoamines et sommeils. V. Etude des relations entre les structures monoaminergiques du pont et les pointes ponto-geniculo occipitales du sommeil. Thèse Médecine, Lyon, 1969. Tixier ed. 214 pp.Google Scholar
  131. — Petitjean, F., Jouvet, M.: Suppression des pointes PGO du sommeil par lésion ou injection in situ de 6-hydroxydopamine au niveau du tegmentum pontique. C. R. Soc. Biol. (Paris) 164, 2293–2298 (1970).Google Scholar
  132. Burkard, W. P., Jalfre, M., Blum, J.: Effect of 6-hydroxydopamine on behaviour and cerebral amine content in rats. Experientia (Basel) 25, 1295–1296 (1969).PubMedGoogle Scholar
  133. Burn, J. H., Rand, M. J.: Acetylcholine in adrenergic transmission. Ann. Rev. Pharmacol. 5, 163–183 (1965).Google Scholar
  134. Calvet, J., Calvet, M. C., Scherrer, J.: Etude stratigraphique corticale de l’activité E.E.G. spontanée. Eletroenceph. clin. Neurophysiol. 17, 109–125 (1964).Google Scholar
  135. Capon, A.: Nouvelles recherches sur l’effet d’éveil de l’adrénaline. J. Physiol. (Paris) 51, 424–425 (1959).Google Scholar
  136. Carli, G., Diete-Spiff, K., Pompeiano, O.: Presynaptic and postsynaptic inhibition on transmission of cutaneous afferent volleys through the cuneate nucleus during sleep. Experientia (Basel) 22, 239–241 (1966).PubMedGoogle Scholar
  137. Carli, G., Zanchetti, A.: A study of pontine lesions suppressing deep sleep in the cat. Arch. ital. Biol. 103, 751–789 (1965).PubMedGoogle Scholar
  138. Carlsson, A.: Functional significance of drug induced changes in brain monoamine levels. In: Biogenic amines. A symposium (H. Himwich and W. A. Himwich, eds.). Amsterdam: Elsevier 1964.Google Scholar
  139. — Lindqvist, M., Fuxe, K., Hökfelt, T.: Histochemical and biochemical effects of diethyldithiocarbamate on tissue catecholamines. J. Pharm. Pharmacol. 18, 60–62 (1966).PubMedGoogle Scholar
  140. — — Magnusson, T., Waldeck, B.: On the presence of 3-hydroxytyramine in brain. Science 127, 471 (1958).PubMedGoogle Scholar
  141. — Meisch, J. T., Waldeck, B.: On the beta-hydroxylation of (±)-α-methyldopamine in vivo. Europ. J. Pharmacol. 5, 85–92 (1968).Google Scholar
  142. Carr, L. A., Moore, K. E.: Release of norepinephrine and normetanephrine from cat brain by central nervous system stimulants. Biochem. Pharmacol. 19, 2671–2675 (1970).PubMedGoogle Scholar
  143. Celesia, G. G., Jasper, H. H.: Acetylcholine released from cerebral cortex in relation to state of activation. Neurology (Minneap.) 16, 1053–1064 (1966).PubMedGoogle Scholar
  144. Chase, T. N., Kopin, J.: Stimulus-induced release of substances from olfactory bulb using the push-pull cannula. Nature (Lond.) 217, 484–485 (1968).Google Scholar
  145. Clemente, C. D., Sterman, M. B., Wyrwicka, W.: Forebrain inhibitory mechanisms: conditioning of basal forebrain induced EEG synchronization and sleep. Exp. Neurol. 7, 404–417 (1963).PubMedGoogle Scholar
  146. Cohen, B., Feldman, M.: Relationship of electrical activity in pontine reticular formation and lateral geniculate body to rapid eye movements. J. Neurophysiol. 31, 806–818 (1968).PubMedGoogle Scholar
  147. — — Diamond, S. P.: Effects of eye movement, brain-stem stimulation, and alertness on transmission through lateral geniculate body of monkey. J. Neurophysiol. 32, 583–595 (1969).PubMedGoogle Scholar
  148. Cohen, H., Ferguson, J., Henriksen, S., Barchas, J., Dement, W.: Reversal of p-chorophenylalanine effects with chlorpromazine. Psychophysiology 6, 221–222 (1969).Google Scholar
  149. — — — Stolk, J. M., Zarcone, V. J., Barchas, J., Dement, W.: Effects of chronic depletion of brain serotonin on sleep and behavior. Proc. Amer. Psychol. Ass. 78, 831–832 (1970).Google Scholar
  150. Colburn, N. G., Kopin, I. J.: Effect of L-DOPA on efflux of cerebral monoamines from synaptosomes. Nature (Lond.) 230, 331–332 (1971).PubMedGoogle Scholar
  151. Collier, B., Mitchell, J. F.: The central release of acetylcholine during consciousness and after brain lesions. J. Physiol. (Lond.) 188, 83–99 (1967).PubMedGoogle Scholar
  152. — —Release of acetylcholine from the cerebral cortex during stimulation of the optic pathway. Nature (Lond.) 210, 424 (1966).PubMedGoogle Scholar
  153. Conner, R. L., Stolk, J. M., Barchas, J. P., Levine, S.: Parachlorophenylalanine and habituation to repetitive auditory startle stimuli in rats. Physiol. Behav. 5, 758–762 (1970).Google Scholar
  154. Consolo, S., Garattini, S., Ghielmetti, R., Morselli, P., Valzelli, L.: The hydroxylation of tryptophan in vivo by brain. Life Sci. 4, 625–630 (1965).PubMedGoogle Scholar
  155. Constantinidis, J., Bartholini, G., Geissbühler, F., Tissot, R.: La barrière capillaire enzymatique pour la DOPA au niveau de quelques noyaux du tronc cérébral du rat. Experientia (Basel) 26, 381–383 (1970).PubMedGoogle Scholar
  156. — — Tissot, R., Pletscher, A.: Accumulation of dopamine in the parenchyma after decarboxylase inhibition in the capillaries of brain. Experientia (Basel) 24, 130–132 (1968).PubMedGoogle Scholar
  157. — Torre, J. C. de la, Tissot, R., Geissbühler, F.: La barrière capillaire pour la DOPA dans le cerveau et les différents organes. Psychopharmacologia (Berl.) 15, 75–87 (1969).PubMedGoogle Scholar
  158. — — — Huggel, H.: Les monoamines cérébrales lors de l’hibernation chez la chauvesouris. Rev. suisse Zool. 77, 345–352 (1970).PubMedGoogle Scholar
  159. Cordeau, J. P.: Functional organization of the brain stem reticular formation in relation to sleep and wakefulness. Rev. canad. Biol. 21, 113–125 (1962).PubMedGoogle Scholar
  160. Monoamines and the physiology of sleep and waking. In: L DOPA and parkinsonism (A. Barbeau and F. H. McCowell, eds.), p. 369–383. Philadelphia: Davis 1970.Google Scholar
  161. — Mancia, M.: Effect of unilateral chronic lesions of the midbrain on the electrocortical activity of the cat. Arch. ital. Biol. 96, 374–379 (1958).Google Scholar
  162. — —Evidence for the existence of an electroencephalographic synchronization mechanism originating in the lower brain stem. Electroenceph. clin. Neurophysiol. 11, 551–564 (1959).PubMedGoogle Scholar
  163. — Moreau, A., Beaulnes, A., Lawrin, C.: EEG and behavioural changes following microinjections of acetylcholine and adrenaline in the brain stem of cats. Arch. ital. Biol. 101, 30–47 (1963).PubMedGoogle Scholar
  164. Corrodi, H., Fuxe, K.: Decrease turnover in central 5-HT nerve terminals induced by antidepressant drugs of the imipramine type. Canad. J. Physiol. Pharmacol. 47, 56–59 (1969).Google Scholar
  165. — — Hökfelt, T.: Replenishment by 5-hydroxytryptophan of the amine stores in the central 5-hydroxytryptamine neurons after depletion induced by reserpine or by an inhibitor of monoamine synthesis. J. Pharm. Pharmacol. 19, 433–438 (1967).PubMedGoogle Scholar
  166. Costa, E.: The role of serotonin in neurobiology. Neurobiology 2, 175–227 (1960).PubMedGoogle Scholar
  167. — Brodie, B. B.: Concept of the neurochemical transducer as an organized molecular unit at sympathetic nerve endings. In: Biogenic amines. A symposium (H. Himwich and W. A. Himwich, eds.). Amsterdam: Elsevier 1964.Google Scholar
  168. — Garattini, S. (eds.): Amphetamines and related compounds. New York: Raven Press 1970.Google Scholar
  169. — Giacobini, E. (eds.): Biochemistry of simple neuronal models. New York: Raven Press 1970.Google Scholar
  170. — Pscheidt, G. R., Meter, W. G. van, Himwich, H. E.: Brain concentrations of biogenic amines and EEG patterns of rabbits. J. Pharmacol. exp. Ther. 130, 81–88 (1960).PubMedGoogle Scholar
  171. Costin, A., Hafemann, D. R.: Relationship between oculomotor nucleus and lateral geniculate body monophasic waves. Experientia (Basel) 26, 972–973 (1970).PubMedGoogle Scholar
  172. Couch, J. R.: Responses of neurons in the raphe neuclei to serotonin, norepinephrine and acetylcholine and their correlation with an excitatory synaptic output. Brain Res. 19, 137–150 (1970).PubMedGoogle Scholar
  173. Coulter, J. D., Lester, B. K., Williams, H. L.: Reserpine and sleep. Psychopharmacologia (Berl.) 19, 134 (1971).PubMedGoogle Scholar
  174. Cramer, H., Kuhlo, W.: Effets des inhibiteurs de la monoamine oxydase sur le sommeil et l’électroencéphalogramme chez l’homme. Acta neurol. belg. 67, 658–669 (1967).Google Scholar
  175. Crawford, J. M.: The sensitivity of cortical neurons to acidic aminoacids and acetylcholine. Brain Res. 17, 287–297 (1970).PubMedGoogle Scholar
  176. Cuculic, Z., Bost, K., Himwich, H. E.: An examination of a possible cortical cholinergic link in the EEG arousal reaction. Progr. Brain Res. 28, 27–39 (1968).Google Scholar
  177. Curtis, D. R.: Acetylcholine as a central transmitter. Symposium on function of acetylcholine as a synaptic transmitter. Canad. J. Biochem. Physiol. 41, 2611–2619 (1963).PubMedGoogle Scholar
  178. — Crawford, J. M.: Central synaptic transmission—microelectrophoretic studies. Ann. Rev. Pharmacol. 9, 209–241 (1969).PubMedGoogle Scholar
  179. — Davis, R.: Pharmacological studies upon neurons of the lateral geniculate nucleus of the cat. Brit. J. Pharmacol. 18, 217–246 (1962).PubMedGoogle Scholar
  180. Dagnino, N., Favale, E., Loeb, C., Manfredi, M.: Sensory transmission in the geniculostriate system of the cat during natural sleep and arousal. J. Neurophysiol. 28, 443–457 (1965).PubMedGoogle Scholar
  181. — — — — Seitun, A.: Accelerated synaptic transmission in nucleus ventralis-posterolateralis during deep sleep. Experientia (Basel) 22, 329–330 (1966).PubMedGoogle Scholar
  182. Dahl, D. R.: Short chain fatty acid inhibition of rat brain NA-K adenosine triphosphatase. J. Neurochem. 15, 815–820 (1968).PubMedGoogle Scholar
  183. Dahlström, A., Fuxe, K.: Evidence for the existence of monoamine neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta physiol. scand. 62, supp. 232 (1964).Google Scholar
  184. — — Evidence for the existence of monoamine neurons in the central nervous system. II. Experimentally induced changes in the intraneuronal amine levels of bulbospinal neuron systems. Acta physiol. scand. 64, Suppl. 247 (1965a).Google Scholar
  185. — —Evidence for the existence of an outflow of noradrenaline nerve fibers in the ventral roots of the rat spinal cord. Experientia (Basel) 21, 409–410 (1965b).PubMedGoogle Scholar
  186. — — Kernell, D., Sedvall, G.: Reduction of the monoamine stores in the terminals of bulbospinbal neurons following stimulation in the medulla oblongata. Life Sci. 4, 1207–1213 (1965).PubMedGoogle Scholar
  187. — — Olson, L., Ungerstedt, U.: Ascending systems of catecholamine neurons from the lower brain stem. Acta physiol. scand. 62, 485–487 (1964).Google Scholar
  188. Dale, H. H.: Pharmacology and nerve endings. Proc. roy. Soc. B 28, 319–332 (1935).Google Scholar
  189. Davis, J. M.: Theories of biological etiology of affective disorders. Int. Rev. Neurobiol. 12, 145–175 (1970).PubMedGoogle Scholar
  190. Dell, P.: Intervention of an adrenergic mechanism during brain stem reticular activation. In: Adrenergic mechanisms. Ciba foundation symposium (Varre, J. R., G. E. W. Wolstenholme and C. M. O’Connor, eds.), p. 393–409. London: Churchill 1960.Google Scholar
  191. Reticular homeostasis and cortical reactivity. In: Brain mechanisms (Moruzzi, G., A. Fessard and H. H. Jasper, eds.), p. 82–103. Amsterdam: Elsevier 1963.Google Scholar
  192. Delorme, F.: Monoamines et sommeils. Etude polygraphique neuropharmacologique et histochimique des états de sommeil chez le chat. Thèse Université de Lyon, Imprimerie LMD 1966. 168 pp.Google Scholar
  193. — Froment, J. L., Jouvet, M.: Suppression du sommeil par la p-chloromethamphetamine et p-chlorophenylalanine. C. R. Soc. Biol. (Paris) 160, 2347–2351 (1966a).Google Scholar
  194. — Jeannerod, M., Jouvet, M.: Effects remarquables de la réserpine sur l’activité EEG phasique pontogeniculo occipitale. C. R. Soc. Biol. (Paris) 159, 900–903 (1965).Google Scholar
  195. — Riotte, M., Jouvet, M.: Conditions de déclenchement du sommeil paradoxal par les acides gras à chaîne courte chez le chat pontique chronique. C. R. Soc. Biol. (Paris) 160, 1457–1460 (1966b).Google Scholar
  196. — Vimont, P., Jouvet, D.: Etude statistique du cycle veille-sommeil chez le chat. C. R. Soc. Biol. (Paris) 158, 2128–2130 (1964).Google Scholar
  197. Dement, W.: The occurrence of low voltage, fast, electroencephalogram patterns during behavioral sleep in the cat. Electroenceph. clin. Neurophysiol. 10, 291–296 (1958).PubMedGoogle Scholar
  198. The effect of dream deprivation. Science 131, 1705–1707 (1960).PubMedGoogle Scholar
  199. — Ferguson, J., Cohen, H., Barchas, J.: Non chemical methods and data using a biochemical model: The REM quanta, p. 275–325. In: Some current issues in psychochemical research strategies in man (Mandell, A., ed.). New York: Academic Press 1970a.Google Scholar
  200. — Rechtschaffen, A., Gulevich, G.: The nature of the narcoleptic sleep attack. Neurology (Minneap.) 16, 18–34 (1966).PubMedGoogle Scholar
  201. — Zarcone, V., Ferguson, J., Cohen, H., Pivik, T., Barchas, J.: Some parallel findings in schizophrenic patients and serotonin depleted cats. In: Schizophrenia. Current concepts and resaerch (Siva-Sankar, P. J. D., ed.), p. 775–811. New York: Hicksville 1970b.Google Scholar
  202. Desmedt, J. E., La Grutta, G.: The effect of selective inhibition of pseudo cholinesterase on the spontaneous and evoked activity of the cat’s cerebral cortex. J. Physiol. (Lond.) 136, 20–40 (1957).PubMedGoogle Scholar
  203. Deutsch, J. A., Rocklin, K. W.: Amnesia induced by scopolamine and its temporal variations. Nature (Lond.) 216, 89–90 (1967).PubMedGoogle Scholar
  204. Dewhurst, W. G.: New theory of cerebral amine function and its clinical application. Nature (Lond.) 218, 1130–1133 (1968).PubMedGoogle Scholar
  205. Dewhurst W. G., Marley, E.: Action of sympathomimetic and allied amines on the central nervous system of the chicken. Brit. J. Pharmacol. Chemother. 25, 705–728 (1965).Google Scholar
  206. Dixit, B. N., Buckley, J. P.: Circadian changes in brain 5-hydroxytryptamine and plasma. Life Sci. 6, 755–759 (1967).PubMedGoogle Scholar
  207. Dominic, J. A., Moore, K. E.: Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice. Arch. int. Pharmacol. Ther. 178, 166–176 (1969).Google Scholar
  208. Domino, E. F., Stawiski, M.: Effects of the cholinergic antisynthesis agent HC-3 on the awake-sleep cycle of cat. Psychophysiology 7, 315–316 (1971).Google Scholar
  209. — Yamamoto, K.: Nicotine: Effect on the sleep cycle of the cat. Science 150, 637–638 (1965).PubMedGoogle Scholar
  210. — — Dren, A. T.: Role of cholinergic mechanisms in states of wakefulness and sleep. Progr. Brain Res. 28, 113–133 (1968).Google Scholar
  211. Dresse, A.: Importance du système mésencéphalo-télencéphalique noradrénergique comme substratum anatomique du comportement d’autostimulation. Life Sci. 5, 1003–1014 (1966).PubMedGoogle Scholar
  212. Drucker-Colin, R. R., Rojas-Ramirez, J. A., Vera-Trueba, J., Monroy-Ayala, G., Hernandez-Péon, R.: Effect of crossed perfusion of the midbrain reticular formation upon sleep. Brain Res. 23, 269–273 (1970).PubMedGoogle Scholar
  213. Dusan-Peyrethon, D.: Etude dynamique et neuropharmacologique des phénomènes phasiques du sommeil paradoxal. Thèse de Médecine, Lyon: J. Tixier & Fils (ed.) 1968. 111 pp.Google Scholar
  214. — Froment, J. L.: Effets du disulfiram sur les états de sommeil chez le chat. C. R. Soc. Biol. (Paris) 162, 2141–2145 (1968).Google Scholar
  215. — Peyrethon, J., Jouvet, M.: Suppression élective du sommeil paradoxal chez le chat par alpha méthyl-dopa. C. R. Soc. Biol. (Paris) 162, 116–118 (1968).Google Scholar
  216. — — —Etude quantitative des phénomènes phasiques du sommeil paradoxal pendant et après sa déprivation instrumentale. C. R. Soc. Biol. (Paris) 161, 2530–2533 (1967).Google Scholar
  217. Eccleston, D., Padjen, A., Randic, M.: Release of 5-hydroxytryptamine 5-hydroxyindol-3-ylacetic acid in the forebrain by stimulation of midbrain raphe. J. Physiol. (Lond.) 201, 22 pp. (1969).Google Scholar
  218. — Ritchie, I. M., Roberts, M. H. T.: Long term effects of midbrain stimulation on 5-hydroxyindole synthesis in rat brain. Nature (Lond.) 226, 84–85 (1970).PubMedGoogle Scholar
  219. Eränkö, O.: Histochemistry of nervous tissues: catecholamines and cholinesterases. Ann. Rev. Pharmacol. 7, 203–223 (1967).PubMedGoogle Scholar
  220. Erspamer, V. (ed.): 5-hydroxytryptamine and related indole alkylamines. In: Handbook of experimental pharmacology, 928 pp. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  221. Evans, J. I.: Neurochemical basis for sleep. In: The abnormalities of sleep in man (Gastaut, H., E. Lugaresi, G. Berti Coroni and G. Coccagna ed.). 326 pp. Bologna: Aulogaggi 1968.Google Scholar
  222. — Oswald, I.: Some experiments in the chemistry of narcoleptic sleep. Brit. J. Psychiat. 112, 401–404 (1966).PubMedGoogle Scholar
  223. Evetts, K. D., Uretsky, N. J., Iversen, L. L., Iversen, S. D.: Effects of 6-hydroxy-dopamine on CNS catecholamines, spontaneous motor activity and amphetamine induced hyperactivity in rats. Nature (Lond.) 225, 961–962 (1970).PubMedGoogle Scholar
  224. Falck, B., Hillarp, N. A., Thieme, G., Thorp, A.: Fluorescence of catecholamines and related compounds condensed with formaldehyde. J. Histochem. Cytochem. 10, 348–354 (1962).Google Scholar
  225. Feldberg, W., Hellon, R. F., Myers, R. D.: Effects on temperature of monoamines injected into the cerebral ventricles of anaesthetized dogs. J. Physiol. (Lond.) 186, 416–424 (1966).PubMedGoogle Scholar
  226. Feldman, M., Cohen, B.: Electrical activity in the lateral geniculate body of the alert monkey associated with eye movements. J. Neurophysiol. 31, 455–467 (1968).PubMedGoogle Scholar
  227. Feldman, S. M., Waller, H. J.: Dissociation of electrocortical activation and behavioural arousal. Nature (Lond.) 196, 1320–1322 (1962).PubMedGoogle Scholar
  228. Feldstein, A., Chang, F. H., Kucharski, J. M.: Tryptophol, 5-hydroxytryptophol and 5-methoxytryptophol induced sleep in mice. Life Sci. 9, 323–329 (1970).PubMedGoogle Scholar
  229. Ferguson, J., Henriksen, S., Cohen, H., Mitchell, G., Barchas, J., Dement, W. C.: Hypersexuality and behavioral changes in cats caused by administration of p-chlorophenylalanine. Science 168, 499–501 (1970).PubMedGoogle Scholar
  230. Ferry, C. B.: Cholinergic link hypothesis in adrenergic neuroeffector transmission. Physiol. Rev. 46, 420–457 (1966).PubMedGoogle Scholar
  231. Fibiger, H. C., Campbell, B. A.: The effect of para-chlorophenylalanine on spontaneous locomotor activity in the rat. Neuropharmacology 10, 25–32 (1971).PubMedGoogle Scholar
  232. — Lytle, L. D., Campbell, B. A.: Cholinergic modulation of adrenergic arousal in the developing rat. J. comp. physiol. Psychol. 72, 384–390 (1970).PubMedGoogle Scholar
  233. Finley, K. H., Cobb, S.: The capillary bed of the locus coeruleus. J. comp. Neurol. 73, 49–58 (1940).Google Scholar
  234. Fishbein, W., McGaugh, J. L., Swarz, J. R.: Retrograde amnesia: Electroconvulsive shock effects after termination of rapid eye movement sleep deprivation. Science 172, 80–82 (1971).PubMedGoogle Scholar
  235. Florio, V., Scotti de Carolis, A., Longo, V. G.: Observations on the effect of DL-Parachlorophenylalanine on the electroencephalogram. Physiol. Behav. 3, 861–865 (1968).Google Scholar
  236. Frederickson, C. J., Hobson, J. A.: Electrical stimulation of the brain stem and subsequent sleep. Arch. ital. Biol. 108, 564–577 (1970).PubMedGoogle Scholar
  237. Freedman, D. X., Giarman, N. J.: Brain amines, electrical activity and behavior. In: EEG and behavior (Glaser, G. H., ed.), p. 198–243. New York: Basic Books 1963.Google Scholar
  238. Friedman, A. H., Walker, C. A.: Circadian rhythms in rat mid-brain and caudate nucleus biogenic amine levels. J. Physiol. (Lond.) 197, 77–85 (1968).PubMedGoogle Scholar
  239. Froment, J. L., Eskazan, E., Jouvet, M.: Effects du LSD et du methysergide sur les états de sommeil du chat. C. R. Soc. Biol. (Paris) (in press).Google Scholar
  240. Fujimori, M., Himwich, H. E.: Electroencephalographic analyses of amphetamine and its methoxy derivatives with reference to their sites of EEG alerting in the rabbit brain. Int. J. Neuropharmacol. 8, 601–615 (1969).PubMedGoogle Scholar
  241. — — The effect of alpha methyl p-tyrosine on sleep in rabbits. Fed. Proc., Abs. 541 (1971).Google Scholar
  242. Fuller, R. W., Hines, C. W.: Inhibition by p-chloramphetamine of the conversion of 5-hydroxytryptamine to 5-hydroxyindole acetic acid in rat brain. J. Pharm. Pharmacol. 22, 634–635 (1970).PubMedGoogle Scholar
  243. — — Mills, J.: Lowering of brain serotonin level by chloramphetamines. Biochem. Pharmacol. 14, 483–489 (1965).PubMedGoogle Scholar
  244. Fuxe, K.: Evidence for the existence of monoamine neurons in the central nervous system. IV. Distribution of monoamine nerve terminals in the central nervous system. Acta physiol. scand. 64 (Suppl. 247), 39–85 (1965).Google Scholar
  245. — Gunne, L. M.: Depletion of the amine stores in brain catecholamine terminals on amygdaloid stimulation. Acta physiol. scand. 62, 493 (1964).PubMedGoogle Scholar
  246. — Hanson, L. C. F.: Central catecholamine neurons and conditioned avoidance behaviour. Psychopharmacologia (Berl.) 11, 439 (1967).PubMedGoogle Scholar
  247. — Hökfelt, T., Ritzew, M., Ungerstedt, U.: Studies on uptake of intraventricularly administered tritiated noradrenaline and 5-hydroxytryptamine with combined fluorescence histochemical and autoradiographic techniques. Histochemie 16, 186–195 (1968).PubMedGoogle Scholar
  248. — Owman, C.: Cellular localization of monoamines in the area postrema of certain mammals. J. comp. Neurol. 125, 337–355 (1965).PubMedGoogle Scholar
  249. Fuxe, K., Ungerstedt, U.: Localization of 5-hydroxytryptamine uptake in rat brain after intraventricular injection. J. Pharm. Pharmacol. 19, 335–337 (1967).PubMedGoogle Scholar
  250. — —Histochemical studies on the distribution of catecholamines and 5-hydroxytryptamine after intraventricular injections. Histochemie 13, 16–28 (1968).PubMedGoogle Scholar
  251. Gadea-Ciria, E., Jouvet, M.: Corticofugal control of pontine PGO activity in the cat. Psychophysiology — in press.Google Scholar
  252. Gaillard, J. M., Schaeppi, R., Tissot, R.: Potentialisation des effets centraux de la DOPA après inhibition sélective de la décarboxylase extracérébrale. Arch. int. Pharmacol. Thér. 180, 424–437 (1969).Google Scholar
  253. Gal, E. M., Roggeveen, A. E., Millard, S. A.: Dl (214C) p-chlorophenylalanine as an inhibitor of tryptophan 5-hydroxylase. J. Neurochem. 17, 1221–1235 (1970).PubMedGoogle Scholar
  254. Gardiner, J. E.: The inhibition of acetylcholine synthesis in brain by a hemicholinium. Biochem. J. 81, 297–303 (1961).PubMedGoogle Scholar
  255. George, R., Haslett, W. L., Jenden, D. J.: A cholinergic mechanism in the brain-stem reticular formation: induction of paradoxical sleep. Int. J. Pharmacol. 3, 451–552 (1964).Google Scholar
  256. Gerardy, J., Quinaux, N., Maeda, T., Dresse, A.: Analyse des monoamines du locus coeruleus et d’autres structures cérébrales par chromatographie sur couche mince. Arch. int. Pharmacol. Thér. 177, 492–496 (1969).Google Scholar
  257. Gessa, G. L., Crabai, F., Vargiu, L., Spano, P. F.: Selective increase of brain dopamine induced by gamma-hydroxybutyrate: study of the mechanism of action. J. Neurochem. 15, 377–383 (1968).PubMedGoogle Scholar
  258. — Tagliamonte, A., Tagliamonte, P.: Aphrodisiac effect of p-chlorophenylalanine. Science 171, 706 (1971).PubMedGoogle Scholar
  259. Giaquinto, S., Pompeiano, O., Somogyi, I.: Descending inhibitory influences on spinal reflexes during natural sleep. Arch. ital. Biol. 102, 282–308 (1964).PubMedGoogle Scholar
  260. Giarman, N. J.: Neurohumors in the brain. Yale J. Biol. Med. 32, 73–92 (1959).PubMedGoogle Scholar
  261. — Roth, R. H.: Differential estimation of gamma butyrolactone and gamma hydroxybutyric acid in rat blood and brain. Science 145, 583–584 (1964).PubMedGoogle Scholar
  262. — Schmidt, K. F.: Some neurochemical aspects of the depressant action of 3-butyrolactone on the central nervous system. Brit. J. Pharmacol. Chemother. 20, 563–568 (1963).Google Scholar
  263. Glowinski, J.: Storage and release of monoamines in the central nervous system. In: Handbook of neurochemistry, vol. 4. New York-London: Plenum Press 1970.Google Scholar
  264. — Axelrod, J., Iversen, L. L.: Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3Norepinephrine and H3Dopamine. J. Pharmacol. exp. Ther. 153, 30–42 (1966a).PubMedGoogle Scholar
  265. — — Kopin, I. J., Wurtman, R. J.: Physiological disposition of H3Norepinephrine in the developing rat. J. Pharmacol. exp. Ther. 146, 48–54 (1964).PubMedGoogle Scholar
  266. — Baldessarini, R. J.: Metabolism of norepinephrine in the central nervous system. Pharmacol. Rev. 18, 1201–1238 (1966).PubMedGoogle Scholar
  267. — Iversen, L. L., Axelrod, J.: Storage and synthesis of norepinephrine in the reserpinetreated rat brain. J. Pharmacol. exp. Ther. 151, 385–400 (1966b).PubMedGoogle Scholar
  268. Godin, Y., Mark, J., Mandel, P.: The effects of 4-hydroxybutyric acid on the biosynthesis of amino acids in the central nervous system. J. Neurochem. 15, 1085–1093 (1968).PubMedGoogle Scholar
  269. Goldstein, M., Lauber, E., McKereghan, M. R.: The inhibition of dopamine-β-hydroxylase by tropolone and other chelating agents. Biochem. Pharmacol. 13, 1103 (1964).PubMedGoogle Scholar
  270. —, Nakajima, K.: The effect of disulfiram on catecholamine levels in the brain. J. Pharmacol. exp. Ther. 157, 96–103 (1967).PubMedGoogle Scholar
  271. Gordon, R., Spector, S., Sjoerdsma, A., Udenfriend, S.: Increased synthesis of norepinephrine and epinephrine in the intact rat during exercise and exposure to cold. J. Pharmacol. exp. Ther. 153, 440–448 (1966).PubMedGoogle Scholar
  272. Gottesmann, C.: Reserpine et vigilance chez le rat. C. R. Soc. Biol. (Paris) 160, 2056–2061 (1966).Google Scholar
  273. Green, H., Sawyer, J. L.: Biochemical pharmacological studies with 5-hydroxy-tryptophan, precursor of serotonin. In: Biogenic amines (Himwich ed.). Amsterdam: Elsevier 1964.Google Scholar
  274. Green, J. R., Halpern, M., Niel, S. van: Choline acetylase and acetylcholine esterase changes in chronic isolated cerebral cortex of cat. Life Sci. 9, 481–489 (1970).PubMedGoogle Scholar
  275. Gulevich, G., Dement, W., Johnson, L.: Psychiatric and EEG observations on a case of prolonged (264 hours) wakefulness. Arch. gen. Psychiat. 15, 29–35 (1966).PubMedGoogle Scholar
  276. Gumulka, W., Samanin, R., Valzelli, L., Consolo, S.: Behavioural and biochemical effects following the stimulation of the nucleus raphis dorsalis on rats. J. Neurochem. 18, 533–534 (1971).PubMedGoogle Scholar
  277. Haggendal, C. J., Dahlström, A. B.: The transport and life-span of amine storage granules in bulbospinal noradrenaline neurons of the rat. J. Pharm. Pharmacol. 21, 55–57 (1969).PubMedGoogle Scholar
  278. Hanig, J. P., Aiello, E., Seifter, J.: Permeability of the blood drain barrier to parenteral 5-hydroxytryptamine in the neonate chick. Europ. J. Pharmacol. 12, 180–182 (1970).Google Scholar
  279. Hanin, I., Massarelli, R., Costa, E.: Acetylcholine concentrations in rat brain: diurnal oscillations. Science 170, 341–342 (1970).PubMedGoogle Scholar
  280. Hanson, L. C. F.: Biochemical and behavioral effects of tyrosine hydroxylase inhibition. Psychopharmacologia (Berl.) 11, 8–18 (1967a).PubMedGoogle Scholar
  281. Evidence that the central action of (+) amphetamine is mediated via catecholamines. Psychopharmacologia (Berl.) 10, 289–298 (1967b).PubMedGoogle Scholar
  282. — Henning, M.: Effects of α-methyl-dopa on conditioned behaviour in the cat. Psychopharmacologia (Berl.) 11, 1–8 (1967).PubMedGoogle Scholar
  283. Hartmann, E.: Reserpine: its effect on the sleep-dream cycle in man. Psychopharmacologia (Berl.) 9, 242–248 (1966).PubMedGoogle Scholar
  284. On the pharmacology of dreaming sleep (the D state). J. nerv. ment. Dis. 146, 165–173 (1968a).PubMedGoogle Scholar
  285. The effect of LSD and L tryptophane on the sleep dream cycle in the rat. Psychophysiology 4, 390 (1968b).Google Scholar
  286. The biochemistry and pharmacology of the D state (dreaming sleep). Exp. Med. Surg. 27, 105–120 (1969a).PubMedGoogle Scholar
  287. Pharmacological studies of sleep and dreaming chemical and clinical relationships. Biol. Psychiat. 1, 243–258 (1969b).PubMedGoogle Scholar
  288. The D state and norepinephrine dependant systems. In: Sleep and dreaming, p. 308–328 (E. Hartmann, ed.). Boston: Little Brown 1970.Google Scholar
  289. — Chung, R., Ching-Piao, C.: L-Tryptophane and sleep. Psychopharmacology 19, 114 (1971).Google Scholar
  290. Harvey, J. A., Heller, A., Moore, R. Y.: The effect of unilateral and bilateral medial forebrain bundle lesions on brain serotonin. J. Pharmacol. exp. Ther. 140, 103–110 (1963).PubMedGoogle Scholar
  291. Hashimoto, P. H., Maeda, T., Toru, K., Shimizu, N.: Histochemical demonstration of autonomic regions in the central nervous system of the rabbit by means of a monoamine oxydase staining. Med. J. Osaka Univ. 12, 425–464 (1962).PubMedGoogle Scholar
  292. Havliček, V.: The effect of dl-3,4-dihydroxyphenylserine (precursor of noradrenaline) on the ECOG of unrestrained rats. Int. J. Neuropharmacol. 6, 83–89 (1967).PubMedGoogle Scholar
  293. Some aspects of the neurophysiological and neurobiochemical effects of catecholamines on the central nervous system. Verh. dtsch. Ges. exp. Med. 24, 28–34 (1969).Google Scholar
  294. Hazra, J.: Effect of hemicholinium-3 on slow wave and paradoxical sleep of cat. Europ. J. Pharmacol 11, 395–397 (1970).Google Scholar
  295. Hebb, C.: CNS at the cellular level: identity of transmitter agents. Ann. Rev. Physiol. 32, 165–192 (1970).Google Scholar
  296. Heller, A., Harvey, H. A., Moore, R. Y.: A demonstration of a fall in brain serotonin following central nervous system lesions in the rat. Biochem. Pharmacol. 11, 859–866 (1962).PubMedGoogle Scholar
  297. Henley, K., Morrison, A.: Release of organized behavior during desynchronized sleep in cats with pontine lesion. Psychophysiology 6, 245 (1969).Google Scholar
  298. Herman, Z. S.: The effects of noradrenaline on rats behaviour. Psychopharmacologia (Berl.) 16, 369–374 (1970).PubMedGoogle Scholar
  299. Hernandez-Péon, R.: A neurophysiologic model of dreams and hallucinations. J. nerv. ment. Dis. 141, 623–651 (1965a).Google Scholar
  300. A cholinergic hypnogenic limbic forebrain-hindbrain circuit. In: Aspects anatomofonctionnels du sommeil (Jouvet, M. ed.), p. 63–88. Paris: Centre National de la Recherche Scientifique 1965b.Google Scholar
  301. — Chavez-Ibarra, G.: Sleep induced by localized electrical or chemical stimulation of the forebrain. Electroenceph. clin. Neurophysiol., Suppl. 24, 188–198 (1963).Google Scholar
  302. — — Morgane, P. J., Timo-Iara, C.: Limbic cholinergic pathways involved in sleep and emotional behavior. Exp. Neurol. 8, 93–111 (1963).Google Scholar
  303. — O’Flaherty, J. J., Mazzuchelli-O’Flaherty, A. L.: Sleep and other behavioural effects induced by acetylcholinic stimulation of basal temporal cortex and striate structure. Brain Res. 4, 243–267 (1967).PubMedGoogle Scholar
  304. Hery, F., Pujol, J. F., Lopez, M., Macon, J., Glowinski, J.: Increased synthesis and utilization of serotonin in the central nervous system in the rat during paradoxical sleep deprivation. Brain Res. 21, 391–403 (1970).PubMedGoogle Scholar
  305. Hess, W. R.: Das Schlafsyndrom als Folge dienzephaler Reizung. Helv. physiol. pharmacol. Acta 2, 305–344 (1944).Google Scholar
  306. Hiebel, G., Bonvallet, M., Hube, P., Dell, P.: Analyse neurophysiologique de l’action centrale de la d-amphetamine (maxiton). Sem. Hôp. Paris 30, 1880–1885 (1954).PubMedGoogle Scholar
  307. Himwich, H. E., Alpers, H. S.: Psychopharmacologia. Ann. Rev. Pharmacol. 10, 313–334 (1970).PubMedGoogle Scholar
  308. — Himwich, W. A. (eds.): Biogenic amines. Progress in brain research, vol. 8. Amsterdam: Elsevier 1964.Google Scholar
  309. Himwich, W. A., Schade, J. P. (eds.): Horizons in neuropsychopharmacology. Progress in brain research, vol. 16. Amsterdam: Elsevier 1965.Google Scholar
  310. Hishikawa, Y., Cramer, H., Kuhlo, W.: Natural and melatonin induced sleep in young chickens. A behavioral and electrographic study. Exp. Brain Res. 7, 84–88 (1969).PubMedGoogle Scholar
  311. — Nakai, K., Hidenobu, I., Kaneko, Z.: The effect of imipramine, desmethylimipramine and chlorpromazine on the sleep wakefulness cycle of the cat. Electroenceph. clin. Neurophysiol. 19, 518–521 (1965).PubMedGoogle Scholar
  312. Hobson, J. A.: The effects of chronic brain stem lesions on cortical and muscular activity during sleep and waking in the cat. Electroenceph. clin. Neurophysiol. 19, 41–62 (1965).PubMedGoogle Scholar
  313. — Alexander, J., Frederickson, J.: The effect of lateral geniculate lesions on phasic electrical activity of the cortex during desynchronized sleep in the rat. Brain Res. 14, 607–621 (1969).PubMedGoogle Scholar
  314. Hökfelt, T.: On the ultrastructural localization of noradrenalin in the central nervous system of the rat. Z. Zellforsch. 79, 110–118 (1967).PubMedGoogle Scholar
  315. Hösli, L., Monnier, M.: Humoral transmission of sleep and wakefulness. III. Hemodialysis of activating humors during stimulation of the midbrain reticular system. Pflügers Arch. ges. Physiol. 283, 17–25 (1965).Google Scholar
  316. — Tebecis, A. K., Schonwelter, H. P.: A comparison of the effects of monoamines neurons of the bulbar reticular formation. Brain Res. 25, 357–370 (1971).PubMedGoogle Scholar
  317. Hoffman, J. S., Domino, E. F.: Comparative effects of reserpine on the sleep cycle of man and cat. J. Pharmacol. exp. Ther. 170, 190–198 (1969).PubMedGoogle Scholar
  318. Holmes, R. L., Wolstencroft, J. H.: Cholinesterase in the medulla and pons of the cat. J. Physiol. (Lond.) 175, 55 (1964).Google Scholar
  319. Hook, J. B., Moore, K. E.: The renal handling of alpha methyltyrosine. J. Pharmacol. exp. Ther. 168, 310–314 (1969).PubMedGoogle Scholar
  320. Hooper, G. (ed.): Metabolism of amines in the brain, p. 1–74. London: MacMillan 1969.Google Scholar
  321. Hornykiewicz, O.: Dopamine (3-hydroxytyramine) and brain function. Pharmacol. Rev. 18, 925–965 (1966).PubMedGoogle Scholar
  322. Hoyland, J., Shillito, E., Vogt, M.: The effect of parachlorophenylalanine on the behaviour of cats. Brit. J. Pharmacol. 40, 659–667 (1970).Google Scholar
  323. Irie, M.: Metabolic regulations of human growth hormone secretion. Folia endocr. Jap. 44, 977–986 (1968).PubMedGoogle Scholar
  324. Iskander, T. N., Kaelbling, R.: Catecholamines, a dream sleep model and depression. Amer. J. Psychiat. 127, 43–50 (1970).PubMedGoogle Scholar
  325. Iversen, L. L.: Inhibition of catecholamine uptake by 6-hydroxydopamine in rat brain. Europ. J. Pharmacol. 10, 408–410 (1970).Google Scholar
  326. — Uretsky, N. J.: Regional effects of 6-hydroxydopamine on catecholamine containing neurons in rat brain and spinal cord. Brain Res. 24, 364–367 (1970).PubMedGoogle Scholar
  327. Iwama, I., Kawamoto, T., Sakakura, H., Kasamatsu, T.: Responsiveness of cat lateral geniculate at pre-and postsynaptic levels during natural sleep. Physiol. Behav. 1, 45–53 (1966).Google Scholar
  328. Jacobson, M.: Development, specification and diversification of neuronal connections. In: The neurosciences, 2nd study program (F. O. Schmitt, ed.), p. 116–129. New York: The Rockefeller University Press 1970.Google Scholar
  329. Jasper, H. H.: Neurochemical mediators of specific and non-specific cortical activation. In: Attention in neurophysiology (Evans, C. R., and T. B. Mulholland, eds.), p. 317–325. London: Butterworths 1969.Google Scholar
  330. Jeannerod, M.: Organisation de l’activité électrique phasique du sommeil paradoxal. Etude électrophysiologique et neuropharmacologique. Thèse de Médecine, Lyon: LMD ed. 1965. 90 pp.Google Scholar
  331. Les phénomènes phasiques du sommeil paradoxical. Rev. lyon. Méd. 18, 171–180 (1966).Google Scholar
  332. Relationships between reserpine induced phasic EEG activity and single unit discharge in the pontine reticular formation and lateral geniculate body neurons. Experientia (Basel) 23, 389–393 (1967).PubMedGoogle Scholar
  333. — Delorme, F., Jouvet, M.: Modulation des réponses évoquées visuelles au cours de l’activité phasique provoquée par la réserpine. C. R. Soc. Biol. (Paris) 159, 1718–1721 (1965).Google Scholar
  334. — Kiyono, S.: Effets de la réserpine sur la réponse réticulaire aux stimulations sensorielles. Brain Res. 12, 129–137 (1969a).PubMedGoogle Scholar
  335. — —Décharge unitaire de la formation réticulée pontique et activité phasique pontogéniculo-occipitale chez le chat sous réserpine. Brain Res. 12, 112–128 (1969b).PubMedGoogle Scholar
  336. — Mouret, J., Jouvet, M.: Effets secondaires de la déafferentation visuelle sur l’activité électrique phasique ponto-géniculo-occipitale du sommeil paradoxal. J. Physiol. (Paris) 57, 255–256 (1965b).Google Scholar
  337. — Putkonen, P. T. S.: Oculomotor influences on lateral geniculate body neurons. Brain Res. 24, 125–129 (1970).PubMedGoogle Scholar
  338. — Sakai, K.: Occipital and geniculate potentials related to eye movements in the unanesthetized cat. Brain Res. 19, 361–377 (1970).PubMedGoogle Scholar
  339. Jequier, E., Lovenberg, W., Sjoerdsma, A.: Tryptophan hydroxylase inhibition: the mechanism by which p-chlorphenylalanine depletes rat brain serotonin. Molec. Pharmacol. 3, 274–279 (1967).Google Scholar
  340. Jones, B.: The double role of catecholamines in waking and paradoxical sleep: A neuropharmacological model. PHD thesis, University of Delaware, 1970.Google Scholar
  341. Hallucinating like behavior elicited in cats by elevation of catecholamines in the central nervous system. Psychophysiology 7, 314 (1971).Google Scholar
  342. Catecholamine containing neurons in the brain stem of the cat and their role in waking. MA thesis, Lyon: Tixier 1969. 87 pp.Google Scholar
  343. Jones, B., Bobillier, P., Jouvet, M.: Effets de la destruction des neurones contenant des catecholamines du mesencephale sur le cycle veille-sommeil du chat. C. R. Soc. Biol. (Paris) 163, 176–180 (1969).Google Scholar
  344. Jouvet, D., Delorme, F.: Evolution des signes électriques du sommeil paradoxal au cours de la narcose au pentobarbital chez le chat. C. R. Soc. Biol. (Paris) 159, 387–390 (1965).Google Scholar
  345. Jouvet, M.: Recherches sur les structures nerveuses et les mécanismes responsables des différentes phases du sommeil physiologique. Arch. ital. Biol. 100, 125–206 (1962).PubMedGoogle Scholar
  346. Etude de la dualité des états de sommeil et des mécanismes de la phase paradoxale. In: Aspects anatomo-fonctionnels de la physiologie du sommeil (M. Jouvet, ed.), p. 397–449. Paris: Centre National de la Recherche Scientifique 1965a.Google Scholar
  347. Etude électrophysiologique et neuropharmacologique des états de sommeil. Actualités pharmacol. 18, 109–173 (1965b).PubMedGoogle Scholar
  348. — Behavioural and EEG effects of paradoxical sleep deprivation in the cat. In: Proceedings of the 23rd international congress of physiological sciences, Tokyo 1965, vol. 4. Excerpta medica Internat. Congress series, No 87, p. 344–355 (1965c).Google Scholar
  349. Paradoxical sleep—a study of its nature and mechanisms. Progr. Brain Res. 18, 20–57 (1965d).Google Scholar
  350. Sommeil et monoamines. Bull. schweiz. Akad. med. Wiss. 22, 287–305 (1966).PubMedGoogle Scholar
  351. Neurophysiology of the states of sleep. Physiol. Rev. 47, 117–177 (1967a).PubMedGoogle Scholar
  352. Mechanisms of the states of sleep: a neuropharmacological approach. Res. Publ. Ass. nerv. ment. Dis. 45, 86–126 (1967b).Google Scholar
  353. The states of sleep. Sci. Amer. 216, 62–72 (1967c).PubMedGoogle Scholar
  354. — Neuropharmacology of sleep. In: Psychopharmacology. A review of progress (Efron, D. H., ed.), p. 523–540. Public Health Service Publication No 1836, 1968.Google Scholar
  355. Neurophysiologische Mechanismen im Schlaf. In: Der Schlaf. Neurophysiologische Aspekte, S. 103–135. München: J. Ambrosius Barth 1969a.Google Scholar
  356. Biogenic amines and the states of sleep. Science 163, 32–41 (1969b).PubMedGoogle Scholar
  357. Some monoaminergic mechanisms controlling sleep and waking. In: Brain and human behavior (Karczmar, A., and J. Eccles, eds.). Berlin-Heidelberg-New York: Springer 1971 (in press).Google Scholar
  358. — Cier, A., Mounier, D., Valatx, J. L.: Effets du 4 butyrolactone et du 4 hydroxybutyrate de sodium sur l’EEG et le comportement du chat. C. R. Soc. Biol. (Paris) 155, 1313–1316 (1961).Google Scholar
  359. — Delorme, J. F.: Locus coeruleus et sommeil paradoxal. C. R. Soc. Biol. (Paris) 159, 895–899 (1965).Google Scholar
  360. — Michel, F.: Corrélations électromyographiques du sommeil chez le chat décortique et mésencéphalique chronique. C. R. Soc. Biol. (Paris) 153, 422–425 (1959).Google Scholar
  361. — — Courjon, J.: Sur un stade d’activité électrique cérébrale rapide au cours du sommeil physiologique. C. R. Soc. Biol. (Paris) 153, 1024–1028 (1959).Google Scholar
  362. — Mounier, D.: Effets des lésions de la formation réticulée pontique sur le sommeil du chat. C. R. Soc. Biol. (Paris) 154, 2301–2305 (1960).Google Scholar
  363. — Vimont, P., Delorme, F.: Suppression élective du sommeil paradoxal chez le chat par les inhibiteurs de la monoamine oxydase. C. R. Soc. Biol. (Paris) 159, 1595–1599 (1965).Google Scholar
  364. Jouvet-Mounier, D.: Ontogenèse des états de vigilance chez quelques mamifères. Thèse de Sciences, Lyon: J. Tixier 1968. 231 pp.Google Scholar
  365. — Astic, L., Lacote, D.: Ontogenesis of the states of sleep in rat, cat and guinea pig during the first postnatal month. Develop. Psychobiol. 2, 216–239 (1970).Google Scholar
  366. Jung, R.: Der Schlaf. In: Physiologie und Pathophysiologie des vegetativen Nervensystems. Hippokrates: Stuttgart 1963.Google Scholar
  367. Kadzielawa, K., Widy-Tyszkiewicz, E.: Electroencephalographic analysis of the central action of dihydroxyphenylalanine. Electroenceph. clin. Neurophysiol. 28, 259–266 (1970a).PubMedGoogle Scholar
  368. Kadzielawa, K., Widy-Tyszkiewicz, E.: The influence of various pharmacological agents on the desynchronization produced by dopa in the cerveau isolé preparation. Electroenceph. clin. Neurophysiol. 28, 266–272 (1970b).PubMedGoogle Scholar
  369. Kales, A. (ed.): Sleep. Physiology and pathology. A symposium. Philadelphia: J. B. Lippincott 1969.Google Scholar
  370. Karczmar, A. G.: Is the central cholinergic nervous system over exploited? Fed. Proc. 28, 147–158 (1969).PubMedGoogle Scholar
  371. — Longo, V. G., Scotti de Carolis, A.: A pharmacological model of paradoxical sleep: the role of cholinergic and monoamine systems. Physiol. Behav. 5, 175–182 (1970).PubMedGoogle Scholar
  372. Katzman, R., Bjorklund, A., Owman, Ch., Stenevi, U., West, K. A.: Evidence for regenerative axon sprouting of central catecholamine neurons in the rat mesencephalon following electrolytic lesion. Brain Res. 25, 579–596 (1971).PubMedGoogle Scholar
  373. Kawai, N.: Release of 5-hydroxytryptamine from slices of superior colliculus by optic tract stimulation. Neuropharmacology 9, 395–397 (1970).PubMedGoogle Scholar
  374. Kawamura, H., Domino, E. F.: Differential actions on m and n cholinergic agonists on the brainstem activating system. Int. J. Neuropharmacol. 8, 105–117 (1969).PubMedGoogle Scholar
  375. : Excitability changes along visual pathways during eye tracking movements. Arch. ital. Biol. 106, 141–157 (1968).PubMedGoogle Scholar
  376. Kety, S. S.: Neurochemical aspects of emotional behavior. In: Physiological correlates of emotion (Block, P., ed.), p. 61–71. New York: Academic Press 1970.Google Scholar
  377. Evarts, E. V., Williams, H. L. (eds.): Sleep and altered states of consciousness. Res. Publ. Ass. nerv. ment. Dis. 45, (1967). 591 pp.Google Scholar
  378. — Javoy, F., Thierry, A. M., Julou, L., Glowinski, J.: A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat. Proc. nat. Acad. Sci. (Wash.) 58, 1249 (1967).PubMedGoogle Scholar
  379. Samson, F. E. (eds.): Neural properties of the biogenic amines. Neurosci. Res. Prog. Bull. 5 (1967).Google Scholar
  380. Key, G. J., Marley, E.: The effect of the sympathomimetic amines on behaviour and electrocortical activity of the chicken. Electroenceph. clin. Neurophysiol. 14, 90–105 (1962).PubMedGoogle Scholar
  381. Khazan, N., Bar, R., Sulman, F. G.: The effect of cholinergic drugs on paradoxical sleep in the rat. Int. J. Neuropharmacol. 6, 279–282 (1967).PubMedGoogle Scholar
  382. — Brown, P.: Differential effects of three tricyclic antidepressants on sleep and REM sleep in the rat. Life Sci. 9, 279–285 (1970).PubMedGoogle Scholar
  383. — Sawyer, C. H.: Mechanisms of paradoxical sleep as revealed by neurophysiologic and pharmacologic approaches in the rabbit. Psychopharmacologia (Berl.) 5, 457–462 (1964).PubMedGoogle Scholar
  384. — Sulman, F. G.: Effect of imipramine on paradoxical sleep in animals with reference to dreaming and enuresis. Psychopharmacologia (Berl.) 10, 89–96 (1966).PubMedGoogle Scholar
  385. King, D., Jewett, R. E.: The effects of alpha methyltyrosine on sleep and brain norepinephrine in cat. J. Pharmacol. exp. Ther. 177, 188–194 (1971).PubMedGoogle Scholar
  386. Kiyono, S., Jeannerod, M.: Relations entre l’activité géniculée phasique et les mouvements oculaires chez le chat normal et sous réserpine. C. R. Soc. Biol. (Paris) 161, 1607–1611 (1967).Google Scholar
  387. Klaue, R.: Die bioelektrische Tätigkeit der Großhirnrinde im normalen Schlaf und in der Narkose durch Schlafmittel. J. Psychol. Neurol. (Lpz.) 47, 510–531 (1937).Google Scholar
  388. Klein, M.: Etude polygraphique et phylogénique des états de sommeil. Thèse Université de Lyon, Bosc ed. (1963). 101 pp.Google Scholar
  389. Koe, B. K., Weissman, A.: P-chlorophenylalanine, a specific depletor of brain serotonin. J. Pharmacol. exp. Ther. 154, 499–516 (1966).PubMedGoogle Scholar
  390. Koella, W. P.: Sleep. Its nature and physiological organization. 199 pp. Springfield: Ch. C. Thomas 1967.Google Scholar
  391. Neurohumoral aspects of sleep control. Biol. Psychiat. 1, 161–177 (1969a).PubMedGoogle Scholar
  392. Serotonin and sleep. Exp. Med. Surg. 27, 157–169 (1969b).PubMedGoogle Scholar
  393. Koella, W. P., Czicman, J.: Mechanism of the EEG synchronizing action of serotonin. Amer. J. Physiol. 211, 926–935 (1966).PubMedGoogle Scholar
  394. — Feldstein, A., Czicman, J. S.: The effect of parachlorophenylalanine on the sleep of cats. Electroenceph. clin. Neurophysiol. 25, 481–490 (1968).PubMedGoogle Scholar
  395. — Smythies, J. R., Bull, D. M., Levy, C. K.: Physiological fractionation of the effect of serotonin on evoked potentials. Amer. J. Physiol. 198, 205–212 (1960).PubMedGoogle Scholar
  396. — Trunca, C. M., Czicman, J. S.: Serotonin: Effect on recruiting responses of the cat. Life Sci. 4, 173–183 (1965).PubMedGoogle Scholar
  397. Koelle, G. B.: The histochemical localizations of cholinesterases in the central nervous system of the rat. J. comp. Neurol. 100, 211–235 (1954).PubMedGoogle Scholar
  398. Kopin, I. J.: Storage and metabolism of catecholamines in the role of monoamine oxidase. Pharmacol. Rev. 16, 179–193 (1964).PubMedGoogle Scholar
  399. Biochemical aspect of release of norepinephrine and other amines from sympathetic nerve endings. Pharmacol. Rev. 18, 513–523 (1966).PubMedGoogle Scholar
  400. — Fischer, J. E., Musacchio, J. M., Horst, W. D., Weise, V. K.: “False neurochemical transmitters” and the mechanism of sympathetic blockade by monoamine oxidase inhibitors. J. Pharmacol. exp. Ther. 147, 186–194 (1965).PubMedGoogle Scholar
  401. — Weise, V. K., Sedvall, G. C.: Effect of false transmitters in norepinephrine synthesis. J. Pharmacol. exp. Ther. 170, 246–253 (1969).PubMedGoogle Scholar
  402. Kornmüller, A. E., Lux, H. B., Winkel, K., Klee, M.: Neurohumoral ausgelöste Schlafzustände an Tieren mit gekreuztem Kreislauf unter der Kontrolle von EEG-Ableitungen. Naturwissenschaften 48, 503–505 (1961).Google Scholar
  403. Kostowski, W., Giacalone, E.: Stimulation of various forebrain structures and brain 5HT, 5HIAA, and behaviour in rats. Europ. J. Pharmacol. 7, 176–180 (1969).Google Scholar
  404. — — Garattini, S., Valzelli, L.: Studies on behavioral and biochemical changes in rats after lesion of midbrain raphe. Europ. J. Pharmacol. 4, 371–377 (1968).Google Scholar
  405. — — — —Electrical stimulation of midbrain raphe biochemical, behavioral and bioelectrical effects. Europ. J. Pharmacol. 7, 170–176 (1969).Google Scholar
  406. Krnjevic, K.: Central cholinergic pathways. Fed. Proc. 28, 113–121 (1969).PubMedGoogle Scholar
  407. — Randic, M., Straughan, D. W.: Cortical inhibition. Nature (Lond.) 201, 1294–1296 (1964).PubMedGoogle Scholar
  408. — — —Pharmacology of cortical inhibition. J. Physiol. (Lond.) 184, 78–106 (1966a).PubMedGoogle Scholar
  409. — — —An inhibitory process in the cerebral cortex. J. Physiol. (Lond.) 184, 16–49 (1966b).PubMedGoogle Scholar
  410. — Silver, A.: The distribution of “cholinergic” fibres in the cerebral cortex. J. Physiol. (Lond.) 168, 39 (1963).Google Scholar
  411. Kurokawa, M., Machiyama, Y., Kato, M.: Distribution of acetylcholine in the brain during various states of activity. J. Neurochem. 10, 341–348 (1963).PubMedGoogle Scholar
  412. Laborit, H.: Sodium 4-hydroxybutyrate. Int. J. Neuropharmacol. 3, 433–452 (1964).PubMedGoogle Scholar
  413. Laguzzi, R., Petitjean, F., Pujol, J. F., Jouvet, M.: Effets de la 6-hydroxydopamine intraventriculaire sur les états de sommeil et les monoamines cérébrales du chat. C. R. Soc. Biol. (Paris) (in press).Google Scholar
  414. Lajtha, A. (ed.): Handbook of neurochemistry. New York: Plenum Press 1969.Google Scholar
  415. Laverty, R., Sharman, D. F., Vogt, M.: Action of 2,4,5-trihydroxyphenylethylamine on the storage and release of noradrenaline. Brit. J. Pharmacol. Chemother. 24, 549–561 (1965).Google Scholar
  416. — Taylor, K. M.: Effects of intraventricular 6-hydroxydopamine on rat behaviour and brain catecholamine metabolism. Brit. J. Pharmacol. 40, 836–846 (1970).Google Scholar
  417. Ledebur, I. X., Tissot, R.: Modification de l’activité électrique centrale du lapin sous l’effet de micro-injections de précurseurs des monoamines dans les structures somnogènes bulbaires et pontiques. Electroenceph. clin. Neurophysiol. 20, 370–381 (1966).PubMedGoogle Scholar
  418. Le Gassicke, J., Ashcroft, J. W., Eccleston, D., Evans, J. I., Oswald, I., Ritson, E. B.: The clinical state, sleep and amine metabolism of a tranylcypromine (“Parnate” addict). Brit. J. Psychiat. 111, 357–365 (1965).Google Scholar
  419. Legendre, R., Piéron, H.: Recherches sur le besoin de sommeil consécutif à une veille prolongée. Z. allg. Physiol. 14, 235–262 (1913).Google Scholar
  420. Lewis, P. R., Shute, C. C. D.: The cholinergic limbic system: projections to hippocampal formation, medial cortex, nuclei of the ascending cholinergic reticular system, and the subfornical organ and supra-optic crest. Brain 90, 521–541 (1967).PubMedGoogle Scholar
  421. — — Silver, A.: Confirmation from choline acetylase analyses of a massive cholinergic innervation to the rat hippocampus. J. Physiol. (Lond.) 191, 215 (1967).PubMedGoogle Scholar
  422. Lichtensteiger, W., Langemann, H.: Uptake of exogenous catecholamines by monoamine-containing neurons of the central nervous system: uptake of catecholamines by Arcuato-infundibular neurons. J. Pharmacol. exp. Ther. 151, 400–409 (1966).PubMedGoogle Scholar
  423. Lin, R. C., Costa, E., Neff, N. H., Wang, C. T., Nagai, S. H.: In vivo measurement of 5-hydroxytryptamine turnover rate in the rat brain from the conversion of C14 tryptophan to C145 hydroxytryptamine. J. Pharmacol. exp. Ther. 170, 232–239 (1969).PubMedGoogle Scholar
  424. Lindsley, D. B., Schreiner, L. H., Knowles, W. B., Magoun, H. V.: Behavioral and EEG changes following chronic brain stem lesions in the cat. Electroenceph. clin. Neurophysiol. 2, 483–498 (1950).PubMedGoogle Scholar
  425. Lippmann, W., Lloyd, K.: Dopamine-beta-hydroxylase inhibition by dimethyldithiocarbamate and related compounds. Biochem. Pharmacol. 18, 2501–2517 (1969).Google Scholar
  426. Loizou, L. A.: Projections of the nucleus locus coeruleus in the albino rat. Brain Res. 15, 563–566 (1969).PubMedGoogle Scholar
  427. Uptake of monoamines into central neurons and the blood brain barrier in the infant rat. Brit. J. Pharmacol. 40, 800–813 (1970).Google Scholar
  428. — Salt, P.: Regional changes in monoamines of the rat brain during postnatal development. Brain Res. 20, 467–470 (1970).PubMedGoogle Scholar
  429. Loizzo, A., Longo, V. G.: A pharmacological approach to paradoxical sleep. Physiol. Behav. 3, 91–99 (1968).Google Scholar
  430. Longo, V. G.: Mechanism of the behavioral and electroencephalographic effects of atropine and related compounds. Pharmacol. Rev. 18, 965–996 (1966).PubMedGoogle Scholar
  431. Loup, M., Cadilhac, J.: Le développement des neurones à monoamines du cerveau chez le chaton. C. R. Soc. Biol. (Paris) 164, 1582–1587 (1970).Google Scholar
  432. Luby, E. D., Frohman, C. E., Grisell, J. L., Lenzo, J. E., Gottlieb, J. S.: Sleep deprivation: Effects on behaviour thinking, motor performance and biological energy transfer system. Psychosom. Med. 22, 182–192 (1960).PubMedGoogle Scholar
  433. Luce, G. G.: Current research on sleep and dreams. Publ. Hlth Serv. Publ. No 1389 (1966).Google Scholar
  434. Lucero, M. A.: Lengthening on REM sleep duration consecutive to learning in the rat. Brain Res. 20, 319–322 (1970).PubMedGoogle Scholar
  435. Macchitelli, F. J., Fischetti, D., Montararelli, N.: Changes in behavior and electrocortical activity in the monkey following administration of 5-hydroxytryptophan. Psychopharmacologia (Berl.) 9, 447–456 (1966).PubMedGoogle Scholar
  436. Macon, J. B., Sokoloff, L., Glowinski, J.: Feedback control of rat brain 5-hydroxytryptamine synthesis. J. Neurochem. 18, 323–332 (1971).PubMedGoogle Scholar
  437. MacPhail, E. M., Miller, N. E.: Cholinergic brain stimulation in cats: failure to obtain sleep. J. comp. Physiol. Psychol. 65, 499–503 (1968).PubMedGoogle Scholar
  438. Maeda, T.: Histochemical consideration on the relationship between monoamine oxidase and biogenic amines in the brain. Advanc. Neurol. 13, 812–820 (1970) [in Japanese].Google Scholar
  439. — Abe, T., Shimizu, N.: Histochemical demonstration of aromatic monoamine in the locus coeruleus of the mammalian brain. Nature (Lond.) 188, 326–327 (1960).PubMedGoogle Scholar
  440. — Dresse, A.: Recherches sur le développement du locus coeruleus. Etude des catecholamines au microscope de fluorescence. Acta neurol. belg. 69, 5–10 (1969).Google Scholar
  441. — Gerebtzoff, M. A.: Recherches sur le développement du locus coeruleus. 2. Etude histoenzymologique. Acta neurol. belg. 69, 11–19 (1969).Google Scholar
  442. — Shimizu, N.: Ascending amine fibers from locus coeruleus and other pontine amine neurons to the forebrain of the rat. Brain Res. 36, 19–35 (1972).PubMedGoogle Scholar
  443. Malcolm, L. J., Bruce, I. S. C., Burke, W.: Excitability of the lateral geniculate nucleus in the alert, non-alert and sleeping cat. Exp. Brain Res. 10, 283–297 (1970a).PubMedGoogle Scholar
  444. — Watson, J. A., Burke, W.: PGO waves as unitary events. Brain Res. 24, 130–133 (1970b).PubMedGoogle Scholar
  445. Mancia, M.: EEG and behavioural changes owing to splitting of the brain stem in cats. Electroenceph. clin. Neurophysiol. 27, 487–503 (1969).PubMedGoogle Scholar
  446. — Desiraju, T., Chhina, G. S.: The monkey split brain stem. Effects on the sleep wakefulness cycle. Electroenceph. clin. Neurophysiol. 24, 409–416 (1968).PubMedGoogle Scholar
  447. Mandel, P., Godin, U.: Approches biochimiques au problème du sommeil. In: Aspects anatomo-fonctionnels de la physiologie du sommeil (Jouvet, M., ed.), p. 13–36. Paris: Centre National de la Scientifique Recherche 1965a.Google Scholar
  448. — —Sur l’intervention possible de l’acide gamma aminobutyrique dans le phénomène du sommeil. C. R. Soc. Biol. (Paris) 158, 2475–2477 (1965b).Google Scholar
  449. Mandell, A. J., Mandell, M. P.: Biochemical aspects of rapid eye movement sleep. Amer. J. Psychiat. 122, 391–402 (1965).PubMedGoogle Scholar
  450. — Spooner, C. E.: Psychochemical research studies in man. Science 162, 1442–1453 (1968).PubMedGoogle Scholar
  451. — — An N.N. indole transmethylation theory of the mechanism of MAOI-indole aminoacid load behavioral activation. In: Schizophrenia, current concepts and research (Siva-Sankar, ed.), p. 496–505. New York 1969.Google Scholar
  452. — — Winters, W. D., Cruiksmank, M., Sabbott, I. M.: Imipramine antagonism of the CNS effects of norepinephrine, behavioral and biochemical correlates. Int. J. Neuropharmacol. 8, 235–245 (1969).PubMedGoogle Scholar
  453. Manshardt, J., Wurtman, R. J.: Daily rhythm in the noradrenalin content of rat hypothalamus. Nature (Lond.) 217, 574–575 (1968).PubMedGoogle Scholar
  454. Mantegazzini, P., Glasser, A.: Action de la DL-3-4-dioxyphenylalanine (dopa) et de la dopamine sur l’activité électrique du chat „cerveau isolé“. Arch. ital. Biol. 98, 367–374 (1960).Google Scholar
  455. — Pepe J, G.: Increase of cortical acetylcholine induced by midbrain hemisection in the cat. J. Physiol. (Lond.) 173, 20 (1964).Google Scholar
  456. Marantz, R., Rechtschaffen, A.: Effect of alpha-methyltyrosine on sleep in the rat. Percept. motor skills 25, 805–808 (1967).PubMedGoogle Scholar
  457. — — Lovell, R. A., Whitehead, P. K.: Effect of alpha-methyltyrosine on the recovery from paradoxical sleep deprivation in the rat. Commun. Behav. Biol. 2, 161–164 (1968).Google Scholar
  458. Marcus, R. J., Winters, W. D., Mori, K., Spooner, C. E.: EEG and behavioral comparison of the effects of gamma-hydroxybutyrate, gamma-butyrolactone and short chain fatty acids in the rat. Int. J. Neuropharmacol. 6, 175–187 (1967).PubMedGoogle Scholar
  459. Marczynski, T. J., Yamaguchi, N., Ling, G. M., Grodzinska, L.: Sleep induced by the administration of melatonin to the hypothalamus in unrestrained cats. Experientia (Basel) 20, 435–437 (1964).PubMedGoogle Scholar
  460. Mark, J., Heiner, L., Mandel, P., Godin, U.: Norepinephrine turnover in brain and stress reactions in rats during paradoxical sleep deprivation. Life Sci. 8, 1085–1093 (1969).PubMedGoogle Scholar
  461. Marley, E.: Behavioural and electrophysiological effects of catecholamines. Pharmacol. Rev. 18, 753–768 (1966).PubMedGoogle Scholar
  462. — Key, B. J.: Maturation of the electrocorticogram and behaviour in the kitten and guinea pig and the effect of some sympathomimetic amines. Electroenceph. clin. Neurophysiol. 15, 620–636 (1963).PubMedGoogle Scholar
  463. — Stephenson, J. D.: Effects of catecholamines infused into the brain of young chickens. Brit. J. Pharmacol. 40, 639–658 (1970).Google Scholar
  464. Masai, H., Kusunoki, T., Ishibashi, H.: A histochemical study on the fundamental plan of the central nervous system. Experientia (Basel) 21, 572 (1965).PubMedGoogle Scholar
  465. Matsumoto, J., Jouvet, M.: Effets de réserpine, DOPA et 5HTP sur les 2 états de sommeil. C. R. Soc. Biol. (Paris) 158, 2137–2140 (1964).Google Scholar
  466. Matsumoto, J., Watanabe, S.: Paradoxical sleep: Effects of adrenergic blocking agents. Proc. Jap. Acad. 43, 680–683 (1967).Google Scholar
  467. Matsuzaki, M.: Differential effects of sodium butyrate and physostigmine upon the activities of para-sleep in acute brain stem preparations. Brain Res. 13, 247–265 (1969).PubMedGoogle Scholar
  468. — Kasahara, M.: Induction of para-sleep by cholinesterase inhibitors in the mesencephalic cat. Proc. Jap. Acad. 42, 989 (1966).Google Scholar
  469. — Okada, Y., Shuto, S.: Cholinergic actions related to paradoxical sleep induction in the mesencephalic cat. Experientia (Basel) 23, 1029–1031 (1967).PubMedGoogle Scholar
  470. — Takagi, H.: Sleep induced by sodium butyrate in the cat. Brain Res. 4, 206–222 (1967a).PubMedGoogle Scholar
  471. — —Para-sleep induction by sodium butyrate in acute brain stem preparations. Brain Res. 4, 223–242 (1967b).PubMedGoogle Scholar
  472. — — Tokizane, T.: Paradoxical phase of sleep. Its artificial induction in the cat by sodium butyrate. Science 146, 1328–1329 (1964).PubMedGoogle Scholar
  473. McCarley, R. W., Hobson, J. A.: Cortical unit activity in desynchronized sleep. Science 167, 901–904 (1970).PubMedGoogle Scholar
  474. McGinty, D. J.: Somnolence, recovery and hyposomnia following ventromedial diencephalic lesions in the rat. Electroenceph. clin. Neurophysiol. 26, 70–80 (1969).PubMedGoogle Scholar
  475. — Sterman, M. B.: Sleep suppression after basal forebrain lesions in the cat. Science 160, 1253–1255 (1968).PubMedGoogle Scholar
  476. McIntosh, F. C.: The spontaneous and evoked release of acetylcholine from the cerebral cortex. Canad. J. Biochem. 41, 2555–2571 (1963).Google Scholar
  477. Oborin, P. E.: Release of acetylcholine from intact cerebral cortex. XIX. Int. Physiol. Congr. Montreal 1953. Abstr., p. 580–581.Google Scholar
  478. McLennan, H.: Synaptic transmission. Philadelphia: Saunders 1970. p. 1–173.Google Scholar
  479. The release of acetylcholine and of 3-hydroxytyramine from the caudate nucleus. J. Physiol. (Lond.) 174, 152–161 (1964).PubMedGoogle Scholar
  480. Meter, W. G. van, Ayala, G. F.: EEG effect of intracarotid or intravertebral arterial administration of d-amphetamine in rabbits with basilar artery ligation. Electroenceph. clin. Neurophysiol. 13, 382–384 (1961).Google Scholar
  481. Michel, F.: L’encéphale dédoublé chez le chat. J. Physiol. (Paris) 59, 266 (1967).Google Scholar
  482. — Jeannerod, M., Mouret, J., Rechtshaffen, A., Jouvet, M.: Sur les mécanismes de l’activité de pointes au niveau du système visuel au cours de la phase paradoxale du sommeil. C. R. Soc. Biol. (Paris) 158, 103–106 (1964).Google Scholar
  483. — Roffwarg, H. P.: Chronic split brain stem preparation: effect on the sleep-waking cycle. Experientia (Basel) 23, 126–128 (1967).PubMedGoogle Scholar
  484. Mikiten, T., Niebyl, P., Hendley, C.: EEG desynchronization during behavioural sleep associated with spike discharges from the thalamus of the cat. Fed. Proc. 20, 327 (1961).Google Scholar
  485. Mizuno, N., Nakamura, Y.: Direct hypothalamic projections to the locus coeruleus. Brain Res. 19, 160–162 (1970).PubMedGoogle Scholar
  486. Moir, A. T. B., Eccleston, D.: The effects of precursor loading in the cerebral metabolism of 5-hydroxyindoles. J. Neurochem. 15, 1093–1109 (1968).PubMedGoogle Scholar
  487. Monnier, M.: Le sommeil expérimental et sa transmission humorale. Actualités neurophysiol. 5, 203–237 (1964).PubMedGoogle Scholar
  488. — Fallert, M.: Neurophysiologische und biochemische Mechanismen der Schlafsteuerung. Schweiz. med. Wschr. 97, 866–875 (1967a).PubMedGoogle Scholar
  489. — —Neurophysiologische und biochemische Regulationsmechanismen der Wachfunktion. Wien. klin. Wschr. 79, 509–515 (1967b).PubMedGoogle Scholar
  490. — Graber, S.: Action de DOPA et du blocage de la monoaminoxydase par l’iproniazid sur le cerveau. Sonderdruck Schweiz. Arch. Neurol. Neurochir. Psychiat. 92, 410–414 (1963).Google Scholar
  491. — Hösli, L.: Dyalisis of sleep and waking factors in blood of rabbit. Science 146, 796–798 (1964).PubMedGoogle Scholar
  492. Monnier, M., Hösli, L.: Humoral regulation of sleep and wakefulness by hypnogenic and activating dialysable factors. Progr. Brain Res. 18, 118–123 (1965).Google Scholar
  493. —, Koller, T., Graber, S.: Humoral influences of induced sleep and arousal upon electrical brain activity of animals with crossed circulation. Exp. Neurol. 8, 264–277 (1963)Google Scholar
  494. — Hösli, L.: Humoral mechanism in experimental sleep. In: Aspects anatomofonctionnels de la physiologie du sommeil Jouvet, M., (ed.), p. 37–50. Paris: Centre National de la Recherche Scientifique 1965.Google Scholar
  495. —, Romanowski, W.: Les systèmes cholinoceptifs cérébraux—actions de l’acétylcholine, de la physostigmine, pilocarpine et de GABA. Electroenceph. clin. Neurophysiol. 14, 486–500 (1962).PubMedGoogle Scholar
  496. : Action de la réserpine et de ses médiateurs (5-HTP-serotonine et DOPA-noradrenaline) sur le comportement et le cerveau du lapin. Helv. physiol. pharmacol. Acta 16, 255–267 (1958).Google Scholar
  497. Monti, J. M.: Effect of recurrent stimulation of the brain stem reticular formation on REM sleep in cats. Exp. Neurol. 28, 484–493 (1970).PubMedGoogle Scholar
  498. Moore, K. E.: Effects of disulfiram and diethyldithiocarbamate on spontaneous locomotor activity and brain catecholamine levels in mice. Biochem. Pharmacol. 18, 1627–1634 (1969).PubMedGoogle Scholar
  499. — Wright, P. F., Bert, J. K.: Toxicologic studies with α-methyltyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmacol. exp. Ther. 155, 506–516 (1967).PubMedGoogle Scholar
  500. Moore, R. Y., Heller, R. A.: Monoamine levels and neuronal degeneration in rat brain following lateral hypothalamic lesions. J. Pharmacol. exp. Ther. 156, 12–23 (1967).PubMedGoogle Scholar
  501. —, Wong, S. L. R., Heller, A.: Regional effects of hypothalamic lesions on brain serotonin. Arch. Neurol. (Chic.) 13, 346–354 (1965).PubMedGoogle Scholar
  502. Morden, B., Conner, R., Mitchell, G., Dement, W., Levine, S.: Effect of rapid eye movement sleep deprivation on shock-induced fighting. Physiol. Behav. 3, 425–432 (1968).Google Scholar
  503. Morgane, P. J.: Chemical mapping of hypnogenic and arousal systems in the brain. Psychophysiology 6, 219 (1969).Google Scholar
  504. : Degeneration studies of the rostral projections of the raphe nuclei in the cat. Psychophysiology 7, 317 (1971).Google Scholar
  505. Morrison, A. R., Pompeiano, O.: Vestibular influences during sleep. IV. Functional relations between vestibular nuclei and lateral geniculate nucleus during desynchronized sleep. Arch. ital. Biol. 104, 425–459 (1966).PubMedGoogle Scholar
  506. Moruzzi, G.: Active processes in the brain stem during sleep. In: The Harvey lectures. Series 58, p. 233–297. New York: Academic Press 1963.Google Scholar
  507. The historical development of the deafferentation hypothesis of sleep. Proc. Amer. phil. Soc. 108, 19–28 (1964).Google Scholar
  508. — Magoun, H. W.: Brain stem reticular formation and activation of the E. E. G. Electroenceph. clin. Neurophysiol. 1, 455–473 (1949).PubMedGoogle Scholar
  509. Mouret, J. R., Bobillier, P.: Sleep and brain biogenic amine diurnal rhythms in the rat. I. Alterations of sleep diurnal rhythms independent of light. Int. J. Neurosciences 2, 265–269 (1971).Google Scholar
  510. — — Bobillier, P. Jouvet, M.: Insomnia following parachlorophenylalanine in the rat. Europ. J. Pharmacol. 5, 17–22 (1968a).Google Scholar
  511. — Froment, J. L., Bobillier, P., Jouvet, M.: Etude neuropharmacologique et biochimique des insomnies provoquées par la p-chlorophenylalanine. J. Physiol. (Paris) 59, 463–464 (1967).Google Scholar
  512. — Jeannerod, M., Jouvet, M.: L’activité électrique du système visuel au cours de la phase paradoxale du sommeil chez le chat. J. Physiol. (Paris) 55, 305–306 (1963).Google Scholar
  513. — Vilppula, A., Frachon, N., Jouvet, M.: Effets d’un inhibiteur de la monoamineoxydase sur le sommeil du rat. C. R. Soc. Biol. (Paris) 162, 914–917 (1968b).Google Scholar
  514. Myers, R. D.: Emotional and autonomic responses following hypothalamic chemical stimulation. Canad. J. Psychol. 18, 6–14 (1964).PubMedGoogle Scholar
  515. Transfusion of cerebrospinal fluid and tissue bound chemical factors between the brains of conscious monkeys: a new neurobiological essay. Physiol. Behav. 2, 373–379 (1967).Google Scholar
  516. The role of hypothalamic transmitter factors in the control of body temperature. In: Physiological and behavioral temperature regulation (J. D. Hardy et al., eds.), p. 648–666. Springfield: Ch. Thomas 1970.Google Scholar
  517. — Beleslin, D. B.: The spontaneous release of 5-hydroxytryptamine and acetylcholine within the diencephalon of the unanaesthetized rhesus monkey. Exp. Brain Res. 11, 539–552 (1970).PubMedGoogle Scholar
  518. — Yaksh, T. L.: Feeding and temperature responses in the unrestrained rat after injections of cholinergic and aminergic substances into the cerebral ventricles. Physiol. Behav. 3, 917–929 (1968).Google Scholar
  519. — —Control of body temperature in the unanaesthetized monkey by cholinergic and aminergic systems in the hypothalamus. J. Physiol. (Lond.) 202, 483–501 (1969).PubMedGoogle Scholar
  520. Naquet, R., Denavit, M., Lanoir, J., Albe-Fessard, D.: Altérations transitoires ou définitives de zones diencéphaliques chez le chat. Leurs effets sur l’activité électrique corticale et le sommeil. In: Aspects anatomo-fonctionnels de la physiologie du sommeil (Jouvet, M., ed.). Paris: Centre National de la Recherche Scientifique 1965.Google Scholar
  521. Nauta, W. J. H.: Hypothalamic regulation of sleep in rats. An experimental study. J. Neurophysiol. 9, 285–316 (1946).PubMedGoogle Scholar
  522. Hippocampal projections and related neural pathways to the midbrain of the cat. Brain 81, 319–340 (1958).PubMedGoogle Scholar
  523. — Koella, W. P., Quarton, G. C.: Sleep, wakefulness, dreams and memory. Neurosci. Res. Program Bull. 4, 5–103 (1966).Google Scholar
  524. Neal, M. J., Hemsworth, B. A., Mitchell, J. F.: The excitation of central cholinergic mechanisms by stimulation of the auditory pathway. Life Sci. 7, 757–765 (1968).Google Scholar
  525. Nemoz, C., Henry, P., Jouvet, M., Site, J.: Neuroanatomie biochimique. Utilisation d’un ordinateur pour le traitement des données recueillies après lésion du tronc cérébral chez le chat. Bull. Centre Calcul Université Lyon (Simep, ed.) 1970. 95 pp.Google Scholar
  526. Ng, K. Y., Chase, T. N., Colburn, R. W., Kopin, I. J.: L-Dopa-induced release of cerebral monoamines. Science 170, 76–77 (1970).PubMedGoogle Scholar
  527. Okada, F.: The maturation of the circadian rhythm of brain serotonin in the rat. Life Sci. 10, 77–87 (1971).Google Scholar
  528. Olds, J.: Hypothalamic substrate of reward. Physiol. Rev. 42, 554–604 (1962).PubMedGoogle Scholar
  529. — Yuwiler, A., Olds, M. E., Yun, C.: Neurohumors in hypothalamic substrates of reward. Amer. J. Physiol. 207, 242–255 (1964).PubMedGoogle Scholar
  530. Olivier, A., Parent, A., Simard, H., Poirier, L. J.: Cholinesterase striatopallidal and striatonigral efferents in the cat and the monkey. Brain Res. 18, 273–282 (1970).PubMedGoogle Scholar
  531. Olson, L., Fuxe, K.: On the projections from the locus coeruleus noradrenaline neurons: the cerebellar innervation. Brain Res. 28, 165–171 (1971).PubMedGoogle Scholar
  532. Oswald, I.: Drugs and sleep. Pharmacol. Rev. 20, 273–303 (1968).PubMedGoogle Scholar
  533. — Thacore, V. R.: Some experiments in the chemistry of normal sleep. Brit. J. Psychiat. 112, 391–399 (1966).PubMedGoogle Scholar
  534. Pappenheimer, J. R., Miller, T. B., Goodrich, C. A.: Sleep-promoting effects of cerebrospinal fluid from sleep-deprived goats. Proc. nat. Acad. Sci. (Wash.) 58, 513–518 (1967).PubMedGoogle Scholar
  535. Parent, A., Poirier, L. J.: The medial forebrain bundle (MFB) and ascending monoaminergic pathways in the cat. Canad. J. Physiol. Pharmacol. 47, 781–787 (1969).Google Scholar
  536. Pavlov, I. P.: Conditioned reflexes. Oxford: Oxford University Press 1927. XV + 430 pp.Google Scholar
  537. Pepeu, G., Bartolini, A.: Effect of some psychopharmacological agents on acetylcholine release from the cerebral cortex of the cat. Boll. Soc. ital. Biol. sper. 43, 1409–1411 (1967).PubMedGoogle Scholar
  538. — Mantegazzini, P.: Midbrain hemisection: Effect on cortical acetylcholine in the cat. Science 145, 1069–1070 (1964).PubMedGoogle Scholar
  539. Perenin, M. T., Jeannerod, M.: Lésions internucléaires: effets sur la motricité oculaire pendant l’éveil et le sommeil paradoxal chez le chat. Brain Res. 32, 299–310 (1971).PubMedGoogle Scholar
  540. Petitjean, F.: Etude de l’hypersomnie expérimentale consécutive à une lésion pontomésencéphalique. Thèse 3e cycle Université de Lyon, 1970. 133 pp.Google Scholar
  541. — Jouvet, M.: Hypersomnie et augmentation de l’acide 5-hydroxy-indolacétique cérébral par lésion isthmique chez le chat. C. R. Soc. Biol. (Paris) 164, 2288–2293 (1970).Google Scholar
  542. Peyrethon, J., Dusan-Peyrethon, D.: Etude polygraphique du cycle veille-sommeil d’un Téléostéen (Tinca tinca). C. R. Soc. Biol. (Paris) 161, 2533–2537 (1967).Google Scholar
  543. — —Etude polygraphique du cycle veille-sommeil chez trois genres de reptiles. C. R. Soc. Biol. (Paris) 163, 181–186 (1969).Google Scholar
  544. Phillis, J. W., Chong, G. C.: Acetylcholine release from the cerebral and cerebellar cortices: its role in cortical arousal. Nature (Lond.) 207, 1253–1255 (1965).PubMedGoogle Scholar
  545. — Tebecis, A. K., York, D. H.: The inhibitory action of monoamines on lateral geniculate neurones. J. Physiol. (Lond.) 190, 563–583 (1967a).PubMedGoogle Scholar
  546. — — —A study of cholinoreceptive cells in the lateral geniculate nucleus. J. Physiol. (Lond.) 192, 695–713 (1967b).PubMedGoogle Scholar
  547. — — —The responses of thalamic neurons to iontophoretically applied monoamines. J. Physiol. (Lond.) 192, 715–740 (1967c).PubMedGoogle Scholar
  548. Pieron, H.: Le problème physiologique du sommeil. 520 pp. Paris: Masson 1913.Google Scholar
  549. Pin, C., Jones, B., Jouvet, M.: Topographie des neurones monoaminergiques du tronc cérébral du chat: étude par histofluorescence. C. R. Soc. Biol. (Paris) 162, 2136–2141 (1968).Google Scholar
  550. Pletscher, A., Daprada, M., Bartholini, G., Burkard, W. P., Bruderer, H.: Two types of monoamine liberation by chlorinated aralkylamines. Life Sci. 4, 2301–2309 (1965).PubMedGoogle Scholar
  551. — — Burkard, W. P., Bartholini, G., Steiner, F. A., Bruderer, H., Bigler, F.: Aralkylamines with different effetcs on the metabolism of aromatic monoamines. J. Pharmacol. exp. Ther. 154, 64–73 (1966).PubMedGoogle Scholar
  552. Polc, P., Monnier, M.: An activating mechanism in the ponto-bulbar raphe system of the rabbit. Brain Res. 22, 47–63 (1970).PubMedGoogle Scholar
  553. Pompeiano, O.: Mechanism of sensorimotor integration during sleep. Progr. Physiol. Psychol. 3, 1–179 (1970).Google Scholar
  554. Portig, P. J., Sharman, D. F., Vogt, M.: Release by tubocurarine of dopamine and homovanillic acid from the superfused caudate nucleus. J. Physiol. (Lond.) 194, 565–572 (1968).PubMedGoogle Scholar
  555. Praag, H. M. van: Indoleamines and the central nervous system. Psychiat. Neurol. Neurochir. (Amst.) 73, 9–36 (1970).PubMedGoogle Scholar
  556. Puizillout, J., Ternaux, J. P.: Persistance d’un endormement vago-aortique après destruction chirurgicale et pharmacologique des noyaux du raphé. J. Physiol. (Paris) 63, 272 (1971).Google Scholar
  557. Pujol, J. F.: Contribution à l’étude des modifications de la régulation du métabolisme des monoamines centrales pendant le sommeil et la veille. Thèse de Doctorat ès Sciences, Paris, 1970. 192 pp.Google Scholar
  558. — Bobillier, P., Buguet, A., Jones, B., Jouvet, M.: Biosynthèse de la sérotonine cérébrale: étude neurophysiologique et biochimique après p-chlorophénylalanine et destruction du système du raphé. C. R. Acad. Sci. (Paris) 268, 100–102 (1969).Google Scholar
  559. — Buguet, A., Froment, J. L., Jones, B., Jouvet, M.: The central metabolism of serotonin in the cat during insomnia: A neurophysiological and biochemical study after p-chlorophenylalanine or destruction of the raphe system. Brain Res. 29, 195–212 (1971).PubMedGoogle Scholar
  560. Pujol, J. F., Mouret, J., Jouvet, M., Glowinski, J.: Increased turnover of cerebral norepinephrine during rebound of paradoxical sleep in the rat. Science 159, 112–114 (1968).Google Scholar
  561. Quay, W. B.: Differences in circadian rhythms in 5-hydroxytryptamine according to brain region. Amer. J. Physiol. 215, 1448–1452 (1968).PubMedGoogle Scholar
  562. Rall, T. W., Gilman, A. G.: The role of cyclic AMP in the nervons system. Neurosci. Res. Program Bull. 8, 221–323 (1970).Google Scholar
  563. Ramanamurthy, P. S. U., Srikantia, S. G.: Effects of leucine on brain serotonin. J. Neurochem. 17, 27–32 (1970).PubMedGoogle Scholar
  564. Randic, M., Siminoff, R., Straughan, D.: Acetylcholine depression of cortical neurons. Exp. Neurol. 9, 236–243 (1964).PubMedGoogle Scholar
  565. Ranson, S. W.: Somnolence caused by hypothalamic lesion in the monkey. Arch. Neurol. Psychiat. (Chic.) 41, 1–23 (1939).Google Scholar
  566. Rech, R. M., Borys, H. K., Moore, K. E.: Alterations in behavior and brain catecholamine levels in rats treated with alpha-methyltyrosine. J. Pharmacol. exp. Ther. 153, 412–420 (1966).PubMedGoogle Scholar
  567. Rechtschaffen, A., Lovell, R. A., Freedman, D. W., Whitehead, P. K., Aldrich, M.: Effect of p-chlorophenylalanine on sleep in rats. Psychophysiology 6, 223 (1969).Google Scholar
  568. Reis, D. J., Corvelli, A., Conners, J.: Circadian and ultradian rhythms of serotonin regionally in cat brain. J. Pharmacol. exp. Ther. 167, 328–334 (1969).PubMedGoogle Scholar
  569. — Fuxe, K.: Brain norepinephrine: evidence that neuronal release is essential for sham rage behavior following brain stem transection in cat. Proc. nat. Acad. Sci. (Wash.) 64, 108–112 (1969).PubMedGoogle Scholar
  570. — Gutnick, E.: Daily segmental rhythms of norepinephrine in spinal cord of the cat. Amer. J. Physiol. 218, 1707–1710 (1970).PubMedGoogle Scholar
  571. — Miura, M., Weinbren, M., Gunne, L. M.: Brain catecholamines relation to defense reaction evoked by acute brainstem transection in cat. Science 156, 1768–1770 (1967).PubMedGoogle Scholar
  572. — Moorhead, D. T., Meslino, N.: Dopa induced excitement in the cat. Arch. Neurol. (Chic.) 22, 31–39 (1970).PubMedGoogle Scholar
  573. — Weinbren, M., Corvelli, A.: A circadian rhythm of norepinephrine regionally in cat brain: its relationship to environmental lighting and to regional diurnal variations in brain serotonin. J. Pharmacol. exp. Ther. 164, 135–146 (1968).PubMedGoogle Scholar
  574. — Wurtman, R. J.: Diurnal changes in brain noradrenaline. Life Sci. 7, 91–98 (1968).PubMedGoogle Scholar
  575. Reite, M., Pegram, G. V., Stephens, L. M., Bixler, E. C., Lewis, O. L.: The effect of reserpine and monoamine oxidase inhibitors on paradoxical sleep in the monkey. Psychopharmacologia (Berl.) 14, 12–17 (1969).PubMedGoogle Scholar
  576. Renault, J.: Monoamines et sommeils. Role du système du raphé et de la sérotonine cérébrale dans l’endormissement. Thèse de Médecine, Université Lyon, 1967 (Tixier ed.). 140 pp.Google Scholar
  577. Ribereau-Gayon, P., Sapis, J. C.: Sur la présence dans le vin de tyrosol, de tryptophol d’alcool phenylethylique et de gamma butyrolactone, produits secondaires de la fermentation alcoolique. C. R. Acad. Sci. (Paris) 261, 1915–1916 (1965).Google Scholar
  578. Ricci, G. F., Zamparo, L.: Electrocortical correlates of avoidance conditioning in the monkey. Their modifications with atropine and amphetamine. In: Pharmacology of conditioning, learning and retention (Michelson, M. Y., and V. G. Longo, eds.), p. 269–283. Praha: Czechoslovak medical press 1965.Google Scholar
  579. Rinaldi, F., Himwich, H. E.: Cholinergic mechanism involved in function of mesodiencephalic activating system. Arch. Neurol. Psychiat. (Chic.) 73, 396–402 (1955).Google Scholar
  580. Ringle, D. A., Herndon, B. L.: Plasma dialysates from sleep deprived rabbits and their effect on the electrocorticogram of rats. Pflügers Arch. 303, 344–349 (1968).PubMedGoogle Scholar
  581. — —Effects on rats of CSF from sleep-deprived rabbits. Pflügers Arch. 306, 320–328 (1969).PubMedGoogle Scholar
  582. Rizzoli, A. A., Agosti, S., Galzigna, L.: Interaction between cerebral amines and 4-hydroxybutyrate in the induction of sleep. J. Pharm. Pharmacol. 21, 465–466 (1969).PubMedGoogle Scholar
  583. Rizzoli, A. A., Galzigna, L.: Molecular mechanism of unconscious state induced by butyrate Biochem. Pharmacol. 19, 2727–2736 (1970).Google Scholar
  584. Robertis, E. de, Pellegrino de Iraldi, A., Rodriguez de Lores Arnaiz, G., Zieher, L. M.: Synaptic vesicles from the rat hypothalamus. Isolation and norepinephrine content. Life Sci. 4, 193–201 (1965).Google Scholar
  585. — Rodriguez de Lores Arnaiz, G., Salganicoff, L., Pellegrino de Iraldi, A., Zieher, L. M.: Isolation of synaptic vesicles and structural organization of the acetylcholine system within brain nerve endings. J. Neurochem. 10, 225–235 (1963).Google Scholar
  586. Roberts, M. H. T., Straughan, D. W.: Excitation and depression of cortical neurons by 5-hydroxytryptamine. J. Physiol. (Lond.) 193, 269–295 (1967).PubMedGoogle Scholar
  587. Roberts, R. B., Flexner, J. B., Flexner, L. B.: Some evidence for the involvement of adrenergic sites in the neurons trace. Proc. nat. Acad. Sci. (Wash.) 66, 310–313 (1970).PubMedGoogle Scholar
  588. Robinson, N.: Histochemistry of rat brain stem monoamine oxidase during maturation. J. Neurochem. 15, 1151–1158 (1968).PubMedGoogle Scholar
  589. Rocaboy, J. C., Le Cam, A., Samperez, S., Jouan, P.: Sur la mise en évidence d’une association macromoléculaire de la 5-hydroxytryptamine-14C dans les centres nerveux supérieurs du rat. C. R. Acad. Sci. (Paris) 269, 247–250 (1969).Google Scholar
  590. Roffwarg, H. P., Muzio, J. N., Dement, W. C.: Ontogenetic development of the human sleep-dream cycle. Science 152, 604–619 (1966).PubMedGoogle Scholar
  591. Roll, S. K.: Intracranial self-stimulation and wakefulness. Effect of manipulating ambient brain catecholamines. Science 168, 1370–1372 (1970).PubMedGoogle Scholar
  592. Rossi, G. F.: Sleep-inducing mechanisms in the brain stem. Electroenceph. clin. Neurophysiol., Suppl. 24, 113–132 (1963).Google Scholar
  593. — Favale, E., Hara, T., Giussani, A., Sacco, G.: Researches on the nervous mechanisms underlying deep sleep in the cat. Arch. ital. Biol. 99, 270–292 (1961).Google Scholar
  594. Roth, G. I., Walton, P. L., Yamamoto, W. S.: Area postrema-abrupt EEG synchronization following close intra-arterial perfusion with serotonin. Brain Res. 23, 223–233 (1970).PubMedGoogle Scholar
  595. — Yamamoto, W. S.: The microcirculation of the area postrema in the rat. J. comp. Neurol. 133, 329–341 (1968).PubMedGoogle Scholar
  596. Roth, R. H., Giarman, N. J.: Conversion in vivo of gamma-aminobutyric to gamma-hydroxybutyric acid in the rat. Biochem. Pharmacol. 18, 247–250 (1969).PubMedGoogle Scholar
  597. — —Natural occurrence of gamma-hydroxybutyrate in mammalian brain. Biochem. Pharmacol. 19, 1087–1095 (1970).Google Scholar
  598. — Suhr, Y.: Mechanism of the gamma-hydroxybutyrate induced increase in brain dopamine and its relationship to “sleep”. Biochem. Pharmacol. 19, 3001–3012 (1970).PubMedGoogle Scholar
  599. Rothballer, A. B.: Studies on the adrenaline-sensitive component of the reticular activating system. Electroenceph. clin. Neurophysiol. 8, 603–621 (1956).PubMedGoogle Scholar
  600. The effect of phenylephrine, methamphetamine, cocaine, and serotonin upon the adrenaline sensitive component of the reticular activating system. Electroenceph. clin. Neurophysiol. 9, 409–417 (1957).PubMedGoogle Scholar
  601. The effects of catecholamines on the central nervous system. Pharmacol. Rev. 11, 494–547 (1959).PubMedGoogle Scholar
  602. Rougeul, A., Verdeaux, J., Letalle, A.: Effets électrographiques et comportementaux de divers hallucinogènes chez le chat libre. Rev. neurol. 120, 391–394 (1969).PubMedGoogle Scholar
  603. Roussel, B.: Monoamines et sommeils: Suppression du sommeil paradoxal et diminution de la noradrénaline cérébrale par les lésions des noyaux locus coeruleus. Thèse Médecine, Lyon: Tixier ed. 1967. 141 pp.Google Scholar
  604. — Buguet, A., Bobillier, P., Jouvet, M.: Locus coeruleus—sommeil paradoxal et noradrénaline cérébrale. C. R. Soc. Biol. (Paris) 161, 2537–2541 (1967).Google Scholar
  605. Routtenberg, A.: The two arousal hypothesis: reticular formation and limbic system. Psychol. Rev. 75, 51–80 (1968).PubMedGoogle Scholar
  606. — Malsbury, C.: Brainstem pathways of reward. J. comp. physiol. Psychol. 68, 22–31 (1969).PubMedGoogle Scholar
  607. Routtenberg, A., Sladek, J., Bondareff, W.: Histochemical fluorescence after application of neurochemicals to caudate nucleus and septal area in vivo. Science 161, 272–274 (1968).PubMedGoogle Scholar
  608. Russel, R. W.: Behavioral aspects of cholinergic transmission. Fed. Proc. 28, 121–131 (1969).Google Scholar
  609. Russell, G. V.: The nucleus locus coeruleus (dorso lateralis tegmenti). Tex. Rep. Biol. Med. 13, 939–988 (1955).PubMedGoogle Scholar
  610. Sabelli, H. C., Giardina, W. J.: Tryptaldehydes (indoleacetaldehydes) in serotoninergic sleep in newly hatched chicks. Arzneimittel-Forsch. 20, 74–80 (1970).Google Scholar
  611. — — Alivisatos, S. G., Seth, P. K., Ungar, F.: Aldehydes of brain amines affect central nervous system. Nature (Lond.) 223, 73–74 (1969).PubMedGoogle Scholar
  612. Sakakura, H.: Spontaneous and evoked unitary activities of cat lateral geniculate neurons in sleep and wakefulness. Jap. J. Physiol. 18, 23–43 (1968).Google Scholar
  613. — Iwama, K.: Unitary recording from cat lateral geniculate during natural sleep. Proc. Jap. Acad. 42, 418–423 (1966).Google Scholar
  614. Salmoiraghi, G. C., Bloom, F. E., Costa, E.: Adrenergic mechanisms in rabbit olfactory bulb. Amer. J. Physiol. 207, 1417–1425 (1964).PubMedGoogle Scholar
  615. — Costa, E., Bloom, F. E.: Pharmacology of central synapses. Ann. Rev. Pharmacol. 5, 213–235 (1965).Google Scholar
  616. — Stefanis, C. N.: Patterns of central neurons responses to suspected transmitters. Arch. ital. Biol. 103, 705–725 (1965).PubMedGoogle Scholar
  617. Samson, F. E., Dahl, N., Dahl, D. N.: A study on the narcotic action of the short chain fatty acids. J. clin. Invest. 35, 1291–1298 (1956).PubMedGoogle Scholar
  618. Sanders-Bush, E., Sulser, F.: P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin. J. Pharmacol. exp. Ther. 175, 419–426 (1970).PubMedGoogle Scholar
  619. Saner, A., Thoenen, H.: Model experiments on the molecular mechanism of action of 6-hydroxydopamine. Molec. Pharmacol. 7, 147–155 (1970).Google Scholar
  620. Sassin, J. F., Parker, D. C., Johnson, L. C., Rossman, L. G., Mace, J. W., Gotlin, R. W.: Effects of slow wave sleep deprivation on human growth hormone release in sleep: preliminary study. Life Sci. 8, 1291–1299 (1969a).Google Scholar
  621. — — Mace, J. W., Gotlin, R. W., Johnson, L. C., Rossman, L. G.: Human growth hormone release. Relation to slow wave sleep and sleep-waking cycle. Science 165, 513–515 (1969b).PubMedGoogle Scholar
  622. Satinsky, D.: Pharmacological responsiveness of lateral geniculate nucleus neurons. Int. J. Neuropharmacol. 6, 387–399 (1967).PubMedGoogle Scholar
  623. Satterlee, W. G., Serpick, A., Bianchine, J. R.: The carcinoid syndrome: chronic treatment with para-chlorophenylalanine. Ann. intern. Med. 72, 919–923 (1970).PubMedGoogle Scholar
  624. Schain, R. J., Copenhaver, J. H., Carver, M. J.: Inhibition by phenylalanine of the entry of 5-hydroxy-tryptophan-1-C14 into cerebrospinal fluid. Proc. Soc. exp. Biol. (N.Y.) 118, 184–186 (1965).PubMedGoogle Scholar
  625. Scheckel, C. L., Boff, E.: Behavioral stimulation in rats associated with a selective release of drain norepinephrine. Arch. int. Pharmacodyn. 152, 479–490 (1964).PubMedGoogle Scholar
  626. — Pazery, L. M.: Hyperactive states related to the metabolism of norepinephrine and similar biochemicals. Ann. N.Y. Acad. Sci. 159, 939–958 (1969).PubMedGoogle Scholar
  627. Scheving, L. E., Harrison, W. H., Gordon, P., Pauly, J. E.: Daily fluctuation (circadian and ultradian) in biogenic amines of the rat brain. Amer. J. Physiol. 124, 166–173 (1968).Google Scholar
  628. Schildkraut, J. J.: The catecholamine hypothesis of affective disorders: a review of supporting evidence. Amer. J. Psychiat. 122, 509–523 (1965).PubMedGoogle Scholar
  629. Neuropsychopharmacology and the affective disorders. 111 pp. Boston: Little Brown & Co. 1970.Google Scholar
  630. — Kety, S.: Biogenic amines and emotion. Science 156, 21–30 (1967).PubMedGoogle Scholar
  631. Schmidt, J., Krug, M., Maier, R., Pohle, W., Matthies, H.: Action of noradrenaline, serotonin and acetylcholine on the impulse activity of neurons of the pontine formatio reticularis of the rat. Acta biol. med. germ. 18, 703–713 (1967).PubMedGoogle Scholar
  632. Schmitt, F. O.: Macromolecular specificity and biological moemory (Schmitt, F. O., ed.) Cambridge: MIT Press 1962.Google Scholar
  633. Schnedorf, J. F., Ivy, A. C.: An examination of the hypnotoxin theory of sleep. Amer. J. Physiol. 125, 491–505 (1939).Google Scholar
  634. Schneiderman, N., Monnier, M., Hösli, L.: Humoral transmission of sleep. IV. Cerebral and visceral effects of sleep dialysate. Pflügers Arch. ges. Physiol. 288, 65–81 (1966)iGoogle Scholar
  635. Schoenfeld, R. I., Seiden, L. S.: Effect of alpha-methyltyrosine on operant behavior and brain catecholamine levels. J. Pharmacol. exp. Ther. 167, 319–327 (1969).PubMedGoogle Scholar
  636. Segal, D. S., Mandell, A. J.: Behavioral activation of rats during intraventricular infusion of norepinephrine. Proc. nat. Acad. Sci. (Wash.) 66, 289–293 (1970).PubMedGoogle Scholar
  637. — Whalen, R. E.: Effect of chronic administration of p-chlorophenylalanine on sexual receptivity of the female rat. Psychopharmacologia (Berl.) 16, 434–438 (1970).PubMedGoogle Scholar
  638. Seiden, L. S., Hanson, L. C. F.: Reversal of the reserpine-induced suppression of the conditioned avoidance response in the cat by L-DOPA. Psychopharmacologia (Berl.) 6, 239–245 (1964).PubMedGoogle Scholar
  639. — Peterson, D. D.: Blockade of L-Dopa reversal of reserpine-induced conditioned avoidance response suppression by disulfiram. J. Pharmacol. exp. Ther. 163, 84–90 (1968).PubMedGoogle Scholar
  640. Sharpless, S. K., Rothballer, A. B.: Humoral factors released from intracranial sources during stimulation of reticular formation. Amer. J. Physiol. 200, 909–915 (1961).Google Scholar
  641. Shaskan, E. G., Snyder, S. H.: Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake. J. Pharmacol. exp. Ther. 175, 404–418 (1970).PubMedGoogle Scholar
  642. Sheard, M. H.: The effect of p-chlorophenylalanine on behaviour in rats. Relation to brain serotonin and 5-hydroxyindolacetic acid. Brain Res. 15, 524–528 (1969).PubMedGoogle Scholar
  643. — Aghajanian, G. K.: Neural release of brain serotonin and body temperature. Nature (Lond.) 216, 495–496 (1967).PubMedGoogle Scholar
  644. — —Stimulation of the midbrain raphe: Effect on serotonin metabolism. J. Pharmacol. exp. Ther. 163, 425–431 (1968).PubMedGoogle Scholar
  645. Shimizu, A., Himwich, H. E.: The effects of amphetamine on the sleep-wakefulness cycle of developing kittens. Psychopharmacologia (Berl.) 13, 161–169 (1968).PubMedGoogle Scholar
  646. Shimizu, N., Imamoto, K.: Fine structure of the locus coeruleus in the rat. Arch. Histol. jap. 31, 229–246 (1970).PubMedGoogle Scholar
  647. — Morikawa, N.: Histochemical study of monoamine oxidase in the developing rat brain. Nature (Lond.) 184, 650–651 (1959).PubMedGoogle Scholar
  648. — — Okada, M.: Histochemical studies of monoamine oxidase of the brain of rodents. Z. Zellforsch. 49, 389–400 (1959).Google Scholar
  649. Shute, C. C. D.: The distribution of cholinergic and monoaminergic neurones in the brain. J. Physiol. (Lond.) 201, 2 (1969).Google Scholar
  650. — Lewis, P. R.: Cholinesterase-containing systems of the brain of the rat. Nature (Lond.) 199, 1160–1164 (1963).PubMedGoogle Scholar
  651. — —Cholinergic and monoaminergic systems of the brain. Nature (Lond.) 212, 710–711 (1966).Google Scholar
  652. — —The ascending cholinergic reticular system: neocortical, olfactory and subcortical projections. Brain 90, 497–520 (1967).PubMedGoogle Scholar
  653. Siffre, M., Jouvet, M.: Induction of bicircadian periods by light in isolated man. Psychophysiology — in press.Google Scholar
  654. Siggins, G. R., Hoffer, B. J., Bloom, F. E.: Studies on norepinephrine containing afferents to Purkinje cells of rat cerebellum. III. Evidence for mediation of norepinephrine effects by cyclic 3’5’ adenosine monophosphate. Brain Res. 25, 535–553 (1971).PubMedGoogle Scholar
  655. Simpson, B. A., Iversen, S. D.: Effects of substantia nigra lesions on the locomotor and stereotype responses to amphetamine. Nature (Lond.) 230, 30–32 (1971).Google Scholar
  656. Singer, G., Ho, A., Gershon, S.: Changes in activity of choline acetylase in central nervous system of rat after intraventricular administration of noradrenaline. Nature (Lond.) 230, 152–153 (1971).Google Scholar
  657. Sinha, A. K., Henrikson, S., Dement, W., Barchas, J. D.: Changes in brain amine content in sleep and wakefulness. Amer. J. Physiol. (in press).Google Scholar
  658. Sjoerdsma, A., Engelman, K., Spector, S., Udenfriend, S.: Inhibition of catecholamine synthesis in man with alpha-methyl-tyrosine, an inhibitor of tyrosine hydroxylase. Lancet II, 1092–1094, 1965.Google Scholar
  659. — Lovenberg, W., Engelman, K., Carpenter, W. T., Wyatt, R. J., Gessa, G. L.: Serotonin now: clinical implications of inhibiting its synthesis with parachlorophenylalanine. Ann. intern. Med. 73, 607–629 (1970).Google Scholar
  660. Slater, P.: The effects of triethylcholine and hemicholinium-3 in the acetylcholine content of rat brain. Int. J. Neuropharmacol. 7, 421–429 (1968).PubMedGoogle Scholar
  661. Smythies, J. R. (ed.): The mode of action of psychotomimetic drugs. Neurosci. Res. Progr. Bull. 8 (1970).Google Scholar
  662. Snyder, S. H., Glowinski, J., Axelrod, J.: The storage of norepinephrine and some of its derivatives in brain synaptosomes. Life Sci. 4, 797–809 (1965).PubMedGoogle Scholar
  663. Soderberg, U.: The effect of blood-borne influences of the cerebral cortex in wakefulness and sleep. In: Proceedings of the 22nd international Congress of physiological Sciences. Leyden 1962. Excerpta Medica internat. congress series, p. 457–462 (1962).Google Scholar
  664. Sourkes, T. L.: Action of alpha methyldopa in the brain. Brit. med. Bull. 21, 66–69 (1965).Google Scholar
  665. — Poirier, L.: Influence of the substantia nigra on the concentration of 5-hydroxytryptamine and dopamine of the striatum. Nature (Lond.) 207, 202–203 (1965).PubMedGoogle Scholar
  666. Spafford, D. C.: A study of the influence of the neurohumor serotonin on hibernation in the golden mantled-ground squirrel Citellus lateralis. MA thesis. University of California, Riverside 1970.Google Scholar
  667. Spector, S., Sjoerdsma, A., Udenfriend, S.: Blockade of endogenous norepinephrine synthesis by alpha-methyl-tyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmacol. exp. Ther. 147, 86–96 (1965).PubMedGoogle Scholar
  668. Spooner, C. E., Mandell, A. J., Winters, W. D., Sabbot, I. M., Cruikshank, M. K.: Pharmacological and biochemical correlates of 5-hydroxytryptamine entry into the central nervous system during maturation. Proc. West. Pharmacol. Soc. 11, 98–105 (1968).PubMedGoogle Scholar
  669. — Winters, W. D.: Evidence for a direct action of monoamines on the chick central nervous system. Experientia (Basel) 21, 256–258 (1965).PubMedGoogle Scholar
  670. — —Neuropharmacological profile of the young chick. Int. J. Neuropharmacol. 5, 217–236 (1966).PubMedGoogle Scholar
  671. — —Intra-arterial blood pressure recording in the unrestrained chick during wakefulness and sleep. Arch. int. Pharmacodyn. 161, 1–6 (1966).PubMedGoogle Scholar
  672. — —The influence of centrally active amine induced blood pressure changes on the electroencephalogram and behavior. Int. J. Neuropharmacol. 6, 109–119 (1967).Google Scholar
  673. Squires, R. D., Jacobson, F. H.: Chronic deficits of temperature regulation produced in cat by preoptic lesions. Amer. J. Physiol. 214, 549–553 (1968).PubMedGoogle Scholar
  674. Stein, L., Wise, C. D.: Release of norepinephrine from hypothalamus and amygdala by rewarding medial forebrain bundle stimulation and amphetamine. J. comp. physiol. Psychol. 67, 189–198 (1969).PubMedGoogle Scholar
  675. — —Mechanism of the facilitating effects of amphetamines on behaviour. In: Psychotomimetic drugs (Efron, D. H., ed.), p. 123–145. New York: Raven Press 1970.Google Scholar
  676. — —Possible etiology of schizophrenia: Progressive damage to the noradrenergic reward system by 6-hydroxydopamine. Science 171, 1032–1037 (1971).PubMedGoogle Scholar
  677. Steiner, F. A.: Influence of microelectrophoretically applied acetylcholine on the responsiveness of hippocampal and lateral geniculate neurones. Pflügers Arch. Europ. J. Physiol. 303, 173–181 (1968).Google Scholar
  678. Sterman, M. B., Clemente, C. D.: Forebrain inhibitory mechanisms: cortical synchronization induced by basal forebrain stimulation. Exp. Neurol. 6, 91–102 (1962a).PubMedGoogle Scholar
  679. — —Forebrain inhibitory mechanisms: sleep patterns induced by basal forebrain stimulation in the behaving cat. Exp. Neurol. 6, 103–117 (1962b).PubMedGoogle Scholar
  680. — Knauss, T., Lehmann, D., Clemente, C. D.: Circadian sleep and waking patterns in the laboratory cat. Electroenceph. clin. Neurophysiol. 19, 509–517 (1965).PubMedGoogle Scholar
  681. Stolk, J., Barchas, J., Dement, W., Schauberg, S.: Brain catecholamine metabolism following P chlorophenylalanine treatment. Pharmacologist 11, 258 (1969).Google Scholar
  682. Stolk, J. M., Rech, R. H.: Antagonism of D-amphetamine by alpha-methyl-p-tyrosine: behavioral evidence for the participation of catecholamine stores and synthesis in the amphetamine stimulant response. Neuropharmacology 9, 249–265 (1970).PubMedGoogle Scholar
  683. Stone, E. A., Dicara, L. V.: Activity level and accumulation of tritiated norepinephrine in rat brain. Life Sci. 8, 433–441 (1969).PubMedGoogle Scholar
  684. Svensson, T. H.: The effect of inhibition of catecholamine synthesis on desamphetamine induced central stimulation. Europ. J. Pharmacol. 12, 161–167 (1970).Google Scholar
  685. Sweet, C. P., Hobson, J. A.: The effects of posterior hypothalamic lesions on behavioral and electrographic manifestations of sleep and waking in cats. Arch. ital. Biol. 106, 283–293 (1968).Google Scholar
  686. Szerb, J. C.: The effect of tertiary and quaternary atropine cortical acetylcholine output and on the electroencephalogram in cats. Canad. J. Physiol. Pharmac. 42, 303–314 (1964).Google Scholar
  687. Cortical acetylcholine release and electroencephalographic arousal. J. Physiol. (Lond.) 192, 329–345 (1967).PubMedGoogle Scholar
  688. — Malik, H., Hunter, E. G.: Relationship between acetylcholine content and release in the cat’s cerebral cortex. Canad. J. Physiol. Pharmac. 48, 780–790 (1970).Google Scholar
  689. Taber, E., Brodal, A., Walberg, F.: The raphe nuclei of the brain stem of the cat. I. Normal topography and cytoarchitecture and general discussion. J. comp. Neurol. 114, 161–188 (1960).PubMedGoogle Scholar
  690. Tabushi, K., Himwich, H. E.: The acute effects of reserpine on the sleep-wakefulness cycle in rabbits. Psychopharmacologia (Berl.) 16, 240–252 (1969).PubMedGoogle Scholar
  691. Tagliamonte, A., Tagliamonte, P., Perez-Cruet, J., Gessa, G. L.: Tryptophan increased by treatment with drugs which stimulate synthesis of serotonin. Nature (Lond.) 229, 125–126 (1971).Google Scholar
  692. Takaki, H., Matsuzaki, M.: Sleep state and its induction by sodium butyrate in acute “encephale isolé” and “isolated midbrain pons-medulla” preparations. Jap. J. Physiol. 18, 380–390 (1968).Google Scholar
  693. Tebecis, A. K.: Studies on cholinergic transmission in the medial geniculate nucleus. Brit. J. Pharmacol. 38, 138–147 (1970).Google Scholar
  694. Tenen, S. S.: The effects of p-chlorophenylalanine, a serotonin depletor on avoidance acquisition, pain sensitivity and related behavior in the rat. Psychopharmacologia (Berl.) 10, 204–220 (1967).PubMedGoogle Scholar
  695. Teuber, H. L., in: La fonction du regard. Colloque de l’Institut National de la Santé et de la Recherche Médicale. Dubois, Poulsen, A., C. G. Lairy and A. Remond, edit., p. 187–200. Paris 1971.Google Scholar
  696. Thierry, A. M., Blanc, G., Glowinski, J.: Preferential utilization of newly synthetized norepinephrine in the brain stem of stressed rats. Europ. J. Pharmacol. 10, 139–142 (1970).Google Scholar
  697. — — —Effect of stress on the disposition of catecholamines localized in various intraneuronal storage forms in the brain stem of the rat. J. Neurochem. 18, 449–462 (1971a).PubMedGoogle Scholar
  698. — — —Dopamine-norepinephrine: Another regulatory step of norepinephrine synthesis in central noradrenergic neurons. Europ. J. Pharmacol. 14, 303–307 (1971b).Google Scholar
  699. Thiérry, A. M., Javoy, F., Glowinski, J., Kety, S.: Effects of stress on the metabolism of norepinephrine, dopamine and serotonin in the central nervous system of the rat. J. Pharmacol. exp. Ther. 163, 163–171 (1968).PubMedGoogle Scholar
  700. Thoenen, H., Mueller, R. A., Axelrod, J.: Phase difference in the induction of tyrosine hydroxylase in cell body and nerve terminals of sympathetic neurones. Proc. nat. Acad. Sci. (Wash.) 65, 58–62 (1970).PubMedGoogle Scholar
  701. Thomas, J., Benoit, O.: Individualisation d’un sommeil à ondes lentes et activité phasique. Brain Res. 5, 221–235 (1967).PubMedGoogle Scholar
  702. Tissot, R.: Monoamines et régulations thymiques, p. 87–153. In: Confrontations psychiatriques, vol. 6. Paris: Specia 1970.Google Scholar
  703. Torda, C.: Effect of brain serotonin depletion on sleep in rats. Brain Res. 6, 375–377 (1967).PubMedGoogle Scholar
  704. Effects of changes of brain norepinephrine content of sleep cycle in rat. Brain Res. 10, 200–207 (1968).PubMedGoogle Scholar
  705. Toru, M., Hingtgen, J. N., Aprison, M. H.: Acetylcholine concentrations in brain areas of rats during three states of avoidance behavior: normal, depression and excitation. Life Sci. 5, 181–188 (1966).PubMedGoogle Scholar
  706. Trendelenburg, U.: Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol. Rev. 18, 629–640 (1966).PubMedGoogle Scholar
  707. Tsuchiya, K., Toru, M., Kobayashi, T.: Sleep deprivation-changes of monoamines and acetylcholine. Life Sci. 8, 867–873 (1969).PubMedGoogle Scholar
  708. Udenfriend, S., Weissbach, H., Bogdanski, D. G.: Increase in tissue serotonin following administration of its precursor. 5HTP. J. biol. Chem. 224, 803–810 (1957).Google Scholar
  709. Ungerstedt, U.: 6-Hydroxydopamine induced degeneration of central monoamine neurons. Europ. J. Pharmacol. 5, 107–111 (1969).Google Scholar
  710. — Noradrenaline pathways in the rat brain. Principal structures. Science (in press).Google Scholar
  711. — Arbuthnott, G. W.: Quantitative recording rotational behaviour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 21, 485–493 (1970).Google Scholar
  712. Uretsky, N. J., Iversen, L. L.: Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain. J. Neurochem. 17, 269–278 (1970).PubMedGoogle Scholar
  713. — Simmonds, M. A., Iversen, L. L.: Changes in the retention and metabolism of H-1-norepinephrine in rat brain in vivo after 6-hydroxydopamine pretreatment. J. Pharmacol. exp. Ther. 176, 489–496 (1971).PubMedGoogle Scholar
  714. Ursin, R.: Sleep stage relations within the sleep cycles of the cat. Brain Res. 19, 91–99 (1970).Google Scholar
  715. Valatx, J. L., Jouvet, D., Jouvet, M.: Evolution électroencéphalographique des différents états de sommeil chez le chaton. Electroenceph. clin. Neurophysiol. 17, 218–233 (1964).PubMedGoogle Scholar
  716. Valleala, P.: The temporal relation of unit discharge in visual cortex and activity of the extraocular muscles during sleep. Arch. ital. Biol. 105, 1–15 (1967).PubMedGoogle Scholar
  717. Velasco, M., Lindsley, D. B.: Role of orbital cortex in regulation of thalamocortical electrical activity. Science 149, 1375–1377 (1965).PubMedGoogle Scholar
  718. Velluti, R., Hernandez-Péon, R.: Atropine blockade within a cholinergic hypnogenic circuit. Exp. Neurol. 8, 20–29 (1963).Google Scholar
  719. Villablanca, J.: Electroencephalogram in the permanently isolated forebrain of the cat. Science 138, 44–45 (1962).PubMedGoogle Scholar
  720. Ocular behavior in the chronic cerveau isolé cat. Brain Res. 2, 99–102 (1966a).PubMedGoogle Scholar
  721. Behavioral and polygraphic study of “sleep” and wakefulness in chronic decreebrate cats. Electroenceph. clin. Neurophysiol. 21, 562–577 (1966b).PubMedGoogle Scholar
  722. Effects of atropine, eserine and adrenaline in cats with mesencephalic transection and in the “isolated hemisphere” cat preparation. Arch. Biol. Med. Exp. 3, 118–129 (1966c).Google Scholar
  723. Vimont-Vicary, P.: La suppression des différents états de sommeil. Etude comportementale, EEG, et Neuropharmacologique chez le chat. Thèse Université de Lyon, L.M.D. ed. (1966). 95 pp.Google Scholar
  724. — Jouvet-Mounier, D., Delorme, F.: Effects EEG et comportementaux des privations de sommeil paradoxal chez le chat. Electroenceph. clin. Neurophysiol. 20, 439–449 (1966).PubMedGoogle Scholar
  725. Vogt, M.: The concentration of sympathin in different parts of the cerebral nervous system under normal conditions and after the administration of drugs. J. Physiol. (Lond.) 123, 451–481 (1954).PubMedGoogle Scholar
  726. Votava, Z.: Pharmacology of the central cholinergic synapses. Ann. Rev. Pharmacol. 7, 223–241 (1967).PubMedGoogle Scholar
  727. Wada, J. A., McGeer, E. G.: Central aromatic amines and behavior. Arch. Neurol. (Chic.) 14, 129–143 (1966).PubMedGoogle Scholar
  728. — Terao, A.: Effect of parachlorophenylalanine on basal forebrain stimulation. Exp. Neurol. 28, 501–506 (1970).PubMedGoogle Scholar
  729. Wallach, M. B., Winters, W. D., Mandell, A. J., Spooner, C. E.: A correlation of EEG, reticular multiple unit activity and gross behavior following various antidepressant agents in the cat. Electroenceph. clin. Neurophysiol. 27, 563–573 (1969a).PubMedGoogle Scholar
  730. — — — —Effects of antidepressant drugs on wakefulness and sleep in the cat. Electroenceph. clin. Neurophysiol. 27, 574–581 (1969b).PubMedGoogle Scholar
  731. Walsh, J. T., Cordeau, J. P.: Responsiveness in the visual system during various phases of sleep and waking. Exp. Neurol. 11, 80–104 (1965).PubMedGoogle Scholar
  732. Weill-Malherbe, H., Axelrod, J., Tomchick, R.: Blood brain barier for adrenaline. Science 129, 1226–1227 (1959).Google Scholar
  733. Weiner, N.: Regulation of norepinephrine biosynthesis. Ann. Rev. Pharmacol. 10, 273–291 (1970).PubMedGoogle Scholar
  734. Weiss, B. L., Aghajanian, G. K.: Activation of brain serotonin metabolism by heat: role of midbrain raphe neurons. Brain Res. 26, 37–48 (1971).Google Scholar
  735. Weiss, B., Heller, A.: Methodological problems in evaluating the role of cholinergic mechanisms in behavior. Fed. Proc. 28, 135–147 (1969).PubMedGoogle Scholar
  736. Weiss, E., Bordwell, B., Seeger, M., Lee, J., Dement, W., Barchas, J.: Changes in brain serotonin and 5 hydroxy-indole-3 acetic acid in REM sleep deprived rats. Psychophysiology 5, 209 (1968).Google Scholar
  737. Weissman, A., Koe, B. K.: Behavioral effects of L-alpha-methyl-tyrosine hydroxylase inhibitor s. Life Sci. 4, 1037–1049 (1965).PubMedGoogle Scholar
  738. Weitzman, E. D., McGregor, P., Moore, C., Jacoby, J.: The effect of alpha-methyl-paratyrosine on sleep patterns of the monkey. Life Sci. 8, 751–758 (1969).PubMedGoogle Scholar
  739. — Rapport, M. M., McGregor, P., Jacoby, J.: Sleep patterns of the monkey and brain serotonin concentration: Effect of p-chlorophenylalanine. Science 160, 1361–1363 (1968).PubMedGoogle Scholar
  740. Welch, A. S., Welch, B. L.: Reduction of norepinephrine in the lower brainstem by psychological stimulus. Proc. nat. Acad. Sci. (Wash.) 60, 478–482 (1968).PubMedGoogle Scholar
  741. Wende, Ch. van der, Johnson, J. C.: Interaction of serotonin with the catecholamine and norepinephrine oxidation. Biochem. Pharmacol. 19, 1991–2000 (1970a).Google Scholar
  742. — —Interaction of serotonin with the catecholamins. II. Activation and inhibition of adrenochrome formation. Biochem. Pharmacol. 19, 2001–2007 (1970b).Google Scholar
  743. Werman, R.: Criteria for identification of a central nervous system transmitter. Comp. Biochem. Physiol. 18, 745–767 (1966).PubMedGoogle Scholar
  744. West, L. J., Janszen, H. H., Lester, B. K., Cornelisson, F. S.: The psychosis of sleep deprivation. Ann. N.Y. Acad. Sci. 96, 66–70 (1962).PubMedGoogle Scholar
  745. White, R. P., Samson, F. E.: Effects of fatty acids anions on the electroencephalogram of unanesthetized rabbits. Amer. J. Physiol. 186, 271–274 (1956).PubMedGoogle Scholar
  746. Wikler, A.: Pharmacologic dissociation of behaviour and EEG “sleep patterns” in dogs Morphine, N. allylmorphine and atropine. Proc. Soc. exp. Biol. (N.Y.) 79, 261–265 (1952).PubMedGoogle Scholar
  747. Williams, H. L., Lubin, A., Goodnow, J. J.: Impaired performance with acute sleep loss. Psychol. Monogr. 73, 1–26 (1959).Google Scholar
  748. Winters, W. D., Spooner, C. E., A neurophysiological comparison of gamma-hydroxybutyrate with pentobarbital in cats. Electroenceph. clin. Neurophysiol. 18, 287–296 (1965).PubMedGoogle Scholar
  749. Wise, C. D., Ruelius, H. W.: The binding of serotonin in brain: a study in vitro of the influence of physicochemical factors and drugs. Biochem. Pharmacol. 17, 617–633 (1968).PubMedGoogle Scholar
  750. — Stein, L.: Facilitation of brain self-stimulation by central administration of norepinephrine. Science 163, 299–301 (1969).PubMedGoogle Scholar
  751. Wood, J. G.: Electron microscopic localization of amines in central nervous tissue. Nature (Lond.) 209, 1131–1133 (1966).PubMedGoogle Scholar
  752. Woods, J. W.: Behavior of chronic decerebrate rats. J. Neurophysiol. 27, 635–645 (1964).PubMedGoogle Scholar
  753. Wurtman, R. J. (ed.): Brain monoamines and endocrine function. Neurosci. Res. Prog. Bull. 9, No 2, 297 (1971).Google Scholar
  754. Wyatt, R. J., Engelman, K., Kupfer, D. J., Fram, D. H., Sjoerdsma, A., Snyder, F.: Effects of L-tryptophan (a natural sedative) on human sleep. Lancet 1970 II, 842–846.Google Scholar
  755. — — — Sjoerdsma, A., Snyder, F.: Effects of parachlorophenylalanine on sleep in man. Electroenceph. clin. Neurophysiol. 27, 529–532 (1969).PubMedGoogle Scholar
  756. — Fram, D. H., Kupfer, D. J., Snyder, F.: Total prolonged drug-induced REM sleep suppression im anxious-depressed patients. Arch. gen. Psychiat. 24, 145–156 (1971).PubMedGoogle Scholar
  757. — Kupfer, D. J., Scott, J., Robinson, D. S., Snyder, F.: Longitudinal studies of the effect of monoamine oxidase inhibitors on sleep in man. Psychopharmacologia (Berl.) 15, 236–244 (1969).PubMedGoogle Scholar
  758. Wyrwicka, W., Sterman, M. B., Clemente, C. D.: Conditioning of induced electroencephalographic sleep patterns in the cat. Science 137, 616–618 (1962).PubMedGoogle Scholar
  759. Yamaguchi, N., Marczinski, T. J., Lingi, M.: The effects of electrical and chemical stimulation of the preoptic region and some nonspecific thalamic nuclei in unrestrained, waking animals. Electroenceph. clin. Neurophysiol. 15, 145–166 (1963).Google Scholar
  760. Yamamoto, K. I., Domino, E. F.: Nicotine induced EEG and behavioral arousal. Int. J. Neuropharmacol. 4, 359–373 (1965).PubMedGoogle Scholar
  761. — —Cholinergic agonist-antagonist interactions on neocortical and limbic EEG activation. Int. J. Neuropharmacol. 6, 357–375 (1967).PubMedGoogle Scholar
  762. York, D. H.: Possible dopaminergic pathway from substantia nigra to putamen Brain. Res. 20, 233–251 (1970).Google Scholar
  763. Zanchetti, A.: Brain stem mechanisms of sleep. Anesthesiology 28, 81–99 (1967).PubMedGoogle Scholar
  764. Zigmond, M. J., Wurtman, R. J.: Daily rhythm in the accumulation of brain catecholamines synthesized from incubating H3 tyrosine. J. Pharmacol. exp. Ther. 172, 416–423 (1970).PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1972

Authors and Affiliations

  • Michel Jouvet
    • 1
  1. 1.Department of Experimental MedicineSchool of MedicineLyonFrance

Personalised recommendations